Felice Petraglia

Q: What Schools Are Affiliated With Felice Petraglia

Felice Petraglia is affiliated with the following schools: Consorzio ICoN, University of Milan, University of Oxford, University of Pavia, University of Udine, Stanford University, University of Siena, University of Florence

Felice Petraglia's AcademicInfluence.com Rankings

Felice Petraglia

Engineering

#2599

World Rank

#3551

Historical Rank

Biomedical Engineering

#75

World Rank

#76

Historical Rank

engineering Degrees

Felice Petraglia

Philosophy

#3897

World Rank

#6215

Historical Rank

Logic

#1487

World Rank

#2252

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Why Is Felice Petraglia Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Felice Petraglia's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. (2012) (1305)
Inflammation and Pregnancy (2006) (605)
Consensus on women's health aspects of polycystic ovary syndrome (PCOS). (2012) (400)
Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. (1998) (379)
Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. (1996) (359)
Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta (1987) (328)
Genetic, hormonal and metabolic aspects of PCOS: an update (2016) (301)
Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management. (2015) (290)
Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. (1987) (282)
Insulin-lowering agents in the management of polycystic ovary syndrome. (2003) (271)
High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. (2003) (267)
Localization, secretion, and action of inhibin in human placenta. (1987) (262)
Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome (2015) (208)
Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. (2000) (204)
Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. (2013) (197)
Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality. (2002) (194)
Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. (1989) (194)
Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. (2011) (192)
Neuroendocrine mechanisms in pregnancy and parturition. (2010) (189)
Allopregnanolone concentrations and premenstrual syndrome. (2000) (185)
Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat. (1986) (181)
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. (2000) (178)
Dysmenorrhea and related disorders (2017) (178)
Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. (1989) (172)
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics (2018) (170)
Serum Allopregnanolone in Women With Postpartum “Blues” (2001) (165)
Central Deficiency of β-Endorphin in Alcohol Addicts (1982) (164)
Surgical hysteroscopic treatment of cesarean-induced isthmocele in restoring fertility: prospective study. (2011) (161)
Uterine leiomyoma: available medical treatments and new possible therapeutic options. (2013) (159)
Pathogenesis of adenomyosis: an update on molecular mechanisms. (2017) (159)
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment (2011) (157)
Pathogenetic Mechanisms of Deep Infiltrating Endometriosis (2015) (155)
Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. (2013) (148)
Epidemiology and Risk Factors of Uterine Fibroids. (2017) (145)
Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes (2017) (143)
Human placenta and fetal membranes express human urocortin mRNA and peptide. (1996) (143)
Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey (2015) (133)
Expression and secretion of activin A: possible physiological and clinical implications. (2001) (132)
Defining Future Directions for Endometriosis Research (2013) (132)
Recent advances in understanding and managing adenomyosis (2019) (129)
Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19). (2020) (128)
Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy. (2005) (127)
Diagnosing adenomyosis: an integrated clinical and imaging approach. (2020) (125)
The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. (2004) (123)
Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. (1993) (119)
Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. (1999) (117)
Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. (1992) (117)
Prediction of successful induction of labor at term: role of clinical history, digital examination, ultrasound assessment of the cervix, and fetal fibronectin assay. (2003) (116)
Ultrasound mapping system for the surgical management of deep infiltrating endometriosis. (2014) (116)
Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma beta-endorphin levels in the rat. (1982) (116)
Role of medical therapy in the management of uterine adenomyosis. (2018) (113)
Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. (1991) (112)
Presence and synthesis of inhibin subunits in human decidua. (1990) (110)
Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. (1998) (109)
Abnormal concentration of maternal serum activin-A in gestational diseases. (1995) (109)
Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Progetto Menopausa Italia Study Group. (2000) (108)
Transvaginal sonographic features of diffuse adenomyosis in 18–30‐year‐old nulligravid women without endometriosis: association with symptoms (2015) (108)
Predictive value of hormone measurements in maternal and fetal complications of pregnancy. (2002) (108)
Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. (1997) (107)
Endocrinology of human parturition. (2016) (101)
Impaired placental nutrient transport in mice generated by in vitro fertilization. (2012) (101)
Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. (1993) (99)
Exposure to low frequency pulsed electromagnetic fields increases interleukin-1 and interleukin-6 production by human peripheral blood mononuclear cells. (1993) (97)
Maternal risk factors for preterm birth: a country-based population analysis. (2011) (97)
Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. (1998) (97)
Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients With Deep Infiltrating Endometriosis (2014) (95)
Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin (1995) (94)
Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. (1998) (94)
Activin A in Mammalian Physiology. (2019) (93)
Postterm pregnancy (1996) (92)
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. (2007) (90)
The changing prevalence of infertility (2013) (90)
Inhibin, activin and follistatin in the human placenta--a new family of regulatory proteins. (1997) (88)
Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. (2005) (87)
Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. (1993) (87)
Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. (1983) (86)
Endothelial Cell Adhesion to the Extracellular Matrix Induces c-Src–Dependent VEGFR-3 Phosphorylation Without the Activation of the Receptor Intrinsic Kinase Activity (2010) (85)
Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. (1985) (85)
Progressive impairment of CSF β-EP levels in migraine sufferers (1984) (85)
Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. (2005) (84)
Presence of ACTH and β-endorphin immunoreactive molecules in the freshwater snail Planorbarius corneus (L.) (Gastropoda, Pulmonata) and their possible role in phagocytosis (1990) (84)
Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro. (1994) (84)
Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening. (2010) (84)
Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology (1999) (84)
Psychoimmunoendocrine aspects of panic disorder. (1992) (83)
Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. (2007) (83)
Dementia of the Alzheimer type and hypothalamus‐pituitary‐adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels (1990) (83)
Corticotropin-releasing factor and its binding protein: maternal serum levels in term and preterm deliveries. (1996) (82)
Inflammation: a link between endometriosis and preterm birth. (2012) (82)
Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. (1995) (82)
Gonadal steroid modulation of naloxone-induced LH secretion in the rat. (1984) (82)
Possible involvement of inflammatory/reparative processes in the development of uterine fibroids (2016) (82)
Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in female rats. (1995) (81)
A novel antiinflammatory role for the short-chain fatty acids in human labor. (2012) (79)
Changes in inhibins and activin secretion in healthy and pathological pregnancies (2001) (79)
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia. (2000) (79)
Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. (1997) (79)
Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. (2005) (79)
Activin A stimulates insulin secretion in cultured human pancreatic islets (2000) (78)
Neuroendocrinology of the human placenta (1990) (78)
Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion. (1985) (78)
Lack of Effect of Psychosocial Stress on Maternal Corticotropin-Releasing Factor and Catecholamine Levels at 28 Weeks' Gestation (2001) (78)
Gonadotropin-releasing hormone, inhibin, and activin in human placenta: evidence for a common cellular localization. (1992) (77)
Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. (1999) (77)
Premature ovarian insufficiency: from pathogenesis to clinical management (2015) (77)
Local production and action of follistatin in human placenta. (1994) (76)
Mechanism of action of interleukin-1 beta in increasing corticotropin-releasing factor and adrenocorticotropin hormone release from cultured human placental cells. (1990) (76)
Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome (2015) (76)
Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. (1999) (75)
Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman (2004) (75)
A retrospective case–control study comparing hysteroscopic resection versus hormonal modulation in treating menstrual disorders due to isthmocele (2011) (75)
Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus? (2018) (74)
Hypertension in pregnancy: changes in activin A maternal serum concentration. (1995) (74)
Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. (2000) (73)
Acute Estradiol and Progesterone Administration Reduced Cardiovascular and Catecholamine Responses to Mental Stress in Menopausal Women (1998) (73)
Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat. (1983) (73)
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle (1995) (73)
β-endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women * (1985) (72)
Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. (1991) (72)
Adenosine 3',5'-monophosphate, prostaglandins, and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. (1987) (71)
Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. (2014) (71)
Urocortins in human reproduction (2004) (71)
Metformin treatment is effective in obese teenage girls with PCOS. (2006) (70)
Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-users. (2002) (70)
Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. (2002) (69)
Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. (1986) (69)
The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor. (1998) (69)
Single serum activin a testing to predict ectopic pregnancy. (2007) (69)
Diagnostic Accuracy of S100B Urinary Testing at Birth in Full-Term Asphyxiated Newborns to Predict Neonatal Death (2009) (68)
Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. (2000) (68)
Frequency of Factor V, Prothrombin and Methylenetetrahydrofolate Reductase Gene Variants in Preeclampsia (2002) (68)
Hyperendorphinemia in obese children and adolescents. (1986) (67)
Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women. (2001) (66)
Delaying surgery for patients with a previous SARS-CoV-2 infection (2020) (66)
Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells. (1996) (66)
Naloxone-induced luteinizing hormone secretion in normal, precocious, and delayed puberty. (1986) (66)
Proopiocortin-related peptide plasma levels throughout prepuberty and puberty. (1983) (65)
Activin at Parturition: Changes of Maternal Serum Levels and Evidence for Binding Sites in Placenta and Fetal Membranes (1994) (65)
Hormonal therapy for endometriosis: from molecular research to bedside. (2017) (65)
Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. (1990) (64)
The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre‐eclampsia (2003) (64)
Autophagy is upregulated in ovarian endometriosis: a possible interplay with p53 and heme oxygenase-1. (2015) (64)
Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation (1984) (64)
Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. (1996) (64)
Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. (1984) (63)
Endogenous opioid peptides in uterine fluid. (1986) (63)
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. (2000) (63)
β-endorphin and β-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disorders (1981) (63)
Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts. (1984) (63)
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. (1991) (62)
Stress response in the freshwater snail Planorbarius corneus (L.) (Gastropoda, Pulmonata): interaction between CRF, ACTH, and biogenic amines. (1992) (62)
Inhibins and activins in pregnancy (2004) (61)
Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. (2006) (61)
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type (1992) (61)
Activin A in brain injury. (2007) (61)
Serotoninergic Agonists Increase Plasma Levels of β-Endorphin and β-Lipotropin in Humans (1984) (61)
Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women. (1987) (61)
Activin, inhibin and the human breast (2004) (61)
A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy. (2010) (60)
β‐Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients (1985) (60)
Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women (1996) (60)
Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea. (1998) (59)
Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss. (1990) (59)
Different patterns of central and peripheral βEP, βLPH and ACTH throughout life (1983) (59)
The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis (2006) (59)
A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. (2004) (58)
Opioid control of gonadotrophin secretion in humans. (1993) (58)
Influence of age and sex on serum concentrations of total dimeric activin A. (1998) (57)
Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro. (1995) (57)
Urinary S100B Protein Concentrations Are Increased in Intrauterine Growth-Retarded Newborns (2006) (56)
Hypothalamus-pituitary-adrenal axis of heroin addicts. (1985) (56)
Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery. (1995) (56)
Domperidone in defective and insufficient lactation. (1985) (55)
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome. (2010) (55)
Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. (2002) (54)
Activin A and activin B measured in maternal serum, cord blood serum andamniotic fluid during human pregnancy (1993) (54)
Adenomyosis: Mechanisms and Pathogenesis (2020) (54)
Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women. (1988) (54)
Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. (2006) (54)
Putative Role of Placental Corticotropin-Releasing Factor in the Mechanisms of Human Parturition (1999) (54)
Changes of Serum Allopregnanolone Levels in the First 2 Years of Life and during Pubertal Development (1999) (53)
Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. (2011) (53)
Premenstrual fall of plasma β-endorphin in patients with premenstrual syndrome * (1987) (53)
Mood disorders and quality of life in polycystic ovary syndrome (2015) (53)
Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations (1998) (53)
Changes in placental CRH, urocortins, and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitis. (2011) (53)
Expression of Inflammatory and Neurogenic Mediators in Adenomyosis (2017) (53)
Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure (2020) (53)
Serum and tissue expression of activin a in postmenopausal women with breast cancer. (2002) (52)
Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome (2004) (52)
Effects of Estradiol and Raloxifene Analog on Brain, Adrenal and Serum Allopregnanolone Content in Fertile and Ovariectomized Female Rats (2000) (52)
Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. (2007) (52)
Term histologic chorioamnionitis: a heterogeneous condition. (2015) (51)
Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test. (2000) (51)
Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. (2004) (51)
Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women. (1999) (50)
Colour Doppler changes and thromboxane production after ovarian stimulation with gonadotrophin-releasing hormone agonist. (1997) (49)
Reduced ACTH Content in Cerebrospinal Fluid of Children Affected by Cryptogenic Infantile Spasms with Hypsarrhythmia (1985) (49)
New trends for the medical treatment of endometriosis (2012) (49)
Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. (2006) (49)
Secretion pattern of endogenous opioids in chronic schizophrenia. (1984) (49)
High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage. (2006) (49)
Biochemical markers of perinatal brain damage. (2010) (48)
Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma. (2005) (48)
IL-1β and TGF-β weaken the placental barrier through destruction of tight junctions: an in vivo and in vitro study. (2014) (48)
Benefits and risks of different hormonal replacement therapies in post-menopausal women. (1986) (48)
Is prenatal bonding enhanced by prenatal education courses? (2007) (48)
The brain as a target organ of gonadal steroids (1992) (48)
Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects (2018) (47)
High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension. (1996) (47)
Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition. (1988) (47)
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. (2007) (47)
Second-Trimester Levels of Maternal Serum Human Chorionic Gonadotropin and Inhibin A as Predictors of Preeclampsia in the Third Trimester of Pregnancy (2000) (46)
High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. (2008) (46)
Central ACTH deficit in degenerative and vascular dementia. (1984) (46)
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women. (1997) (46)
Endometrial Expression and Secretion of Activin A, But Not Follistatin, Increase in the Secretory Phase of the Menstrual Cycle (2003) (46)
Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome. (1995) (46)
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic (2020) (46)
Effects of sodium valproate and diazepam on beta-endorphin, beta-lipotropin and cortisol secretion induced by hypoglycemic stress in humans. (1986) (45)
Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. (2019) (45)
Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms. (2015) (45)
Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. (1997) (45)
High levels of fetal membrane activin beta A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor. (1997) (45)
Evidence for local production of inhibin A and activin A in patients with ovarian endometriosis. (2001) (44)
Human Placenta as a Source of Neuroendocrine Factors (2001) (44)
Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues (1999) (44)
Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. (2002) (44)
Reviews: Activins and Related Proteins in the Establishment of Pregnancy (2010) (44)
Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. (1993) (44)
Decreased Endometrial Expression of Leukemia Inhibitory Factor Receptor Disrupts the STAT3 Signaling in Adenomyosis During the Implantation Window (2017) (44)
Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death (2004) (44)
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea. (1995) (44)
Immunomodulation and preeclampsia. (2019) (44)
Differential expression of follistatin and FLRG in human breast proliferative disorders (2009) (43)
High serum follistatin levels in women with ovarian endometriosis. (2007) (43)
Betalipotropin and betaendorphin in physiological and surgical menopause (1981) (43)
Voluminous perinatal pelvic mass: a case of congenital hydrometrocolpos (2004) (43)
Identification of urocortin mRNA and peptide in the human endometrium. (2002) (43)
Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum. (2008) (42)
Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions (2016) (42)
Mechanism of Increased Maternal Serum Total Activin A and Inhibin A in Preeclampsia (2002) (42)
Plasma Urocortin Levels in the Diagnosis of Ovarian Endometriosis (2007) (42)
Estrogens modulate the circadian rhythm of hypothalamic beta-endorphin contents in female rats. (1990) (42)
Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites. (1989) (42)
Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery (1999) (42)
Different releasing effects of traditional manual acupuncture and electro-acupuncture on proopiocortin-related peptides. (1982) (42)
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis. (2016) (42)
Increased expression of antimüllerian hormone and its receptor in endometriosis. (2014) (42)
Impact of Laparoscopic Surgical Management of Deep Endometriosis on Pregnancy Rate. (2016) (41)
Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma (2002) (41)
Placental Corticotropin‐Releasing Factor An Update (2000) (41)
Placental stress factors and maternal-fetal adaptive response (2002) (41)
Impairment of opioid control of luteinizing hormone secretion in menstrual disorders. (1985) (41)
Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage (2012) (40)
Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle. (1998) (40)
Melanocytic skin lesions and pregnancy: digital dermoscopy analysis (2007) (40)
Activin A Plasma Levels at Birth: An Index of Fetal Hypoxia in Preterm Newborn (2003) (40)
Transient failure of central opioid tonus and premenstrual symptoms. (1988) (40)
Blood Cell Mitochondrial DNA Content and Premature Ovarian Aging (2012) (40)
CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration (2016) (40)
Lack of effect of psychosocial stress on maternal corticotropin-releasing factor and catecholamine levels at 28 weeks' gestation. (2001) (39)
The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia. (2004) (39)
High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. (2007) (39)
Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid. (1999) (39)
Effects of sex steroid hormones on the neuroendocrine system. (1997) (39)
A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas (2002) (39)
Involvement of μ-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats (1995) (38)
Psychoimmunoendocrine investigation in anorexia nervosa. (1993) (38)
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis. (2018) (38)
Opioid control of luteinizing hormone secretion in humans. (1989) (38)
Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels (2002) (38)
Second trimester levels of maternal serum total activin A and placental inhibin/activin alpha and betaA subunit messenger ribonucleic acids in Down syndrome pregnancy. (1998) (37)
Opioid plasma levels during labour. (1982) (37)
Ulipristal Acetate Modulates the Expression and Functions of Activin A in Leiomyoma Cells (2014) (36)
ORIGINAL ARTICLE: Urocortin Increases IL‐4 and IL‐10 Secretion and Reverses LPS‐induced TNF‐α Release from Human Trophoblast Primary Cells (2009) (36)
High fetal urocortin levels at term and preterm labor. (2005) (36)
Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders? (2007) (36)
The concomitant release of androstenedione with cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism. (1993) (36)
Endorphin Patterns within the Headache Spectrum Disorders (1985) (36)
Role of Medical Management for Uterine Leiomyomas. (2016) (36)
Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. (2000) (36)
Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding (1985) (35)
Prenatal diagnosis of esophageal atresia with the pouch sign (2003) (35)
Serum activin A and inhibin A (2002) (35)
Placental expression of substance P and vasoactive intestinal peptide: evidence for a local effect on hormone release. (2005) (35)
Oral discomfort and hormone replacement therapy in the post-menopause. (1991) (35)
Raloxifene analog LY 117018 effects on central and peripheral beta-endorphin. (1999) (35)
ESTIMATION OF INSTANTANEOUS SECRETORY RATE OF LUTEINIZING HORMONE IN WOMEN DURING THE MENSTRUAL CYCLE AND IN MEN (1990) (35)
Progesterone and progestins modulate beta-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats. (1987) (35)
Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. (2000) (35)
Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition. (1999) (34)
Surgical scar endometriosis after Cesarean section: A case report (2006) (34)
Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. (2004) (34)
Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis. (2012) (34)
Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy. (2000) (34)
Immunological changes associated with adenomyosis: a systematic review. (2020) (34)
Hypoxia and Preeclampsia: Increased Expression of Urocortin 2 and Urocortin 3 (2010) (34)
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata. (2001) (34)
Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women. (1997) (34)
Stimulation of beta-endorphin and beta-lipotropin release from the anterior but not the neurointermediate pituitary lobe in the rat after acute administration of serotonin-acting drugs. (1982) (34)
Plasma and amniotic fluid immunoreactive neuropeptide-Y level changes during pregnancy, labor, and at parturition. (1989) (34)
Effect of chronic intermittent stress on rat pregnancy and postnatal development. (1993) (34)
Hormonal treatments for endometriosis: The endocrine background (2021) (34)
Changes of Placental Kiss-1 mRNA Expression and Maternal/Cord Kisspeptin Levels at Preterm Delivery (2008) (33)
Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) (33)
Effect of steroid hormones and antihormones on hypothalamic beta-endorphin concentrations in intact and castrated female rats (1990) (33)
Induction of labour: clinical predictive factors for success and failure (2018) (33)
Beta-endorphin concentrations in the hypothalamus, pituitary and plasma of streptozotocin-diabetic rats with and without insulin substitution therapy. (1986) (33)
Potential influence of in utero and early neonatal exposures on the later development of endometriosis. (2016) (33)
Understanding Spontaneous Preterm Birth (2013) (33)
FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile, and postmenopausal women. (1993) (33)
Endometriosis in Italy: From cost estimates to new medical treatment (2009) (32)
Neuroendocrinology of pregnancy and parturition. (2014) (32)
Urocortin expression is downregulated in human endometrial carcinoma. (2006) (32)
Long-term reliability of fractioned CO2 laser as a treatment for vulvovaginal atrophy (VVA) symptoms (2017) (32)
Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits. (2001) (32)
Oestrous cycle-related LH responsiveness to naloxone: effect of high oestrogen levels on the activity of opioid receptors. (1986) (32)
Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis. (2011) (32)
SOMATOSTATIN AND OXYTOCIN INFUSION INHIBITS THE RISE OF PLASMA β‐ENDORPHIN, β‐LIPOTROPHIN AND CORTISOL INDUCED BY INSULIN HYPOGLYCAEMIA (1986) (32)
Human pericytes isolated from adipose tissue have better differentiation abilities than their mesenchymal stem cell counterparts (2015) (32)
Human placenta and fetal membranes express nerve growth factor mRNA and protein (2006) (32)
Effect of different chronic intermittent stressors and acetyl-l-carnitine on hypothalamic beta-endorphin and GnRH and on plasma testosterone levels in male rats. (1993) (31)
Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A (2003) (31)
Maternal position during non‐stress test and fetal heart rate patterns (2005) (31)
Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response. (2011) (31)
Correlations between plasma levels of opioid peptides and adrenal androgens in prepuberty and puberty. (1983) (31)
Relationship between cerebrospinal fluid β-endorphin and plasma pituitary-gonadal hormone levels in women (1990) (31)
pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade (2006) (31)
Paracrine regulation of human placenta: control of hormonogenesis. (1998) (31)
Phagocytosis and ACTH‐like and β‐Endorphin‐like Molecules in Invertebrate (Molluscan) and in Vertebrate (Human) Cells. (1990) (31)
Activin A Stimulates Interleukin 8 and Vascular Endothelial Growth Factor Release From Cultured Human Endometrial Stromal Cells: Possible Implications for the Pathogenesis of Endometriosis (2012) (31)
Mental health, pain symptoms and systemic comorbidities in women with endometriosis: a cross-sectional study (2017) (31)
Heat-killed Lactobacillus rhamnosus GG modulates urocortin and cytokine release in primary trophoblast cells. (2010) (31)
Opiates and their antagonists modulate luteinizing hormone acting outside the blood brain barrier. (1983) (31)
Prenatal diagnosis and multidisciplinary approach to the congenital gingival granular cell tumor. (2006) (31)
Comparison of two-dimensional and three-dimensional ultrasound in the assessment of the cervix to predict preterm delivery. (2003) (31)
Transvaginal ultrasonography in women receiving emergency contraception. (2003) (31)
An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing. (2008) (30)
Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat. (1987) (30)
Effect of activin-A on progesterone synthesis in human luteal cells. (1994) (30)
Hyperendorphinemia in obesity and relationships to affective state (1986) (30)
Polymorphisms of FAS and FAS ligand genes in preeclamptic women. (2010) (30)
Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies. (2006) (30)
Total inhibin is a potential serum marker for epithelial ovarian cancer. (2007) (30)
Pulsatile fluctuations of plasma‐gonadotropin‐releasing hormone and corticotropin‐releasing factor levels in healthy pregnant women (1994) (30)
Episodic secretion of activin A in pregnant women. (1996) (30)
Effect of acute corticotropin releasing factor on pituitary-adrenocortical responsiveness in elderly women and men (1998) (30)
AISF position paper on liver disease and pregnancy. (2016) (30)
Human placenta and fetal membranes express follistatin-related gene mRNA and protein (2003) (29)
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. (1995) (29)
Blink-startle reflex habituation in 30–34-week low-risk fetuses (2005) (29)
Met-enkephalin enhances follicle-stimulating hormone-dependent progesterone production from cultured granulosa cells. (1986) (29)
Peripheral opioid secretory pattern in anorexia nervosa (1991) (29)
Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. (2007) (29)
Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. (2009) (29)
Plasma Opioid Levels in Post‐traumatic Chronic Headache and Trigeminal Neuralgia: Maintained Response to Acupuncture (1982) (29)
Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age. (2009) (29)
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. (1992) (28)
Tocophobia in the DSM-5 era: Outcomes of a new cut-off analysis of the Wijma delivery expectancy/experience questionnaire based on clinical presentation. (2019) (28)
Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. (2003) (28)
Modern operative hysteroscopy. (2016) (28)
Activin βA subunit is expressed in bovine oviduct (1995) (28)
Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor. (1997) (28)
Expression of Matrix Metalloproteinases in the Mouse Uterus and Human Myometrium During Pregnancy, Labor, and Preterm Labor (2018) (28)
Biochemical and biophysical predictors of the response to the induction of labor in nulliparous postterm pregnancy. (2011) (27)
Electro-cautery of myomas during caesarean section--two case reports. (2002) (27)
Increased Maternal/Fetal Blood S100B Levels Following Systemic Endotoxin Administration and Periventricular White Matter Injury in Preterm Fetal Sheep (2009) (27)
Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour. (1997) (27)
Role of proteoglycans in the organization of periurethral connective tissue in women with stress urinary incontinence. (2007) (27)
Prediction of preterm delivery based on maternal plasma urocortin. (2007) (27)
Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climateric and postmenopausal women (1985) (27)
The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model (2015) (27)
Other uses of homologous skin grafts and skin bank bioproducts. (2005) (27)
New aspects of placental endocrinology (1990) (27)
Low serum and peritoneal fluid concentration of interferon-gamma-induced protein-10 (CXCL10) in women with endometriosis. (2009) (27)
High Levels of Maternal Serum IL‐17 and Activin A in Pregnant Women Affected by Systemic Lupus Erythematosus (2011) (26)
Neuroendocrine aspects of placenta and pregnancy (2012) (26)
Inhibins: paracrine and endocrine effects in female reproductive function. (1999) (26)
Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis. (2015) (26)
Congenital Uterine Malformation by Experts (CUME): diagnostic criteria for T‐shaped uterus (2020) (26)
Plasma and CSF Endorphin Levels in Primary and Symptomatic Headaches (1985) (26)
Activin A in Inflammation, Tissue Repair, and Fibrosis: Possible Role as Inflammatory and Fibrotic Mediator of Uterine Fibroid Development and Growth (2017) (26)
Involvement of Placental Neurohormones in Human Parturition a (1991) (26)
Acute stress- or lipopolysaccharide-induced corticosterone secretion in female rats is independent of the oestrous cycle. (1994) (26)
Effects of urocortin 2 and urocortin 3 on IL-10 and TNF-α expression and secretion from human trophoblast explants. (2011) (26)
High serum concentration of total inhibin in polycystic ovary syndrome. (2008) (26)
Dysregulation of GdA Expression in Endometrium of Women With Endometriosis: Implication for Endometrial Receptivity (2018) (26)
Tissue-Specific Cultured Human Pericytes: Perivascular Cells from Smooth Muscle Tissue Have Restricted Mesodermal Differentiation Ability. (2016) (26)
Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause. (2008) (25)
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. (1997) (25)
Epigenetics of Estrogen and Progesterone Receptors in Endometriosis (2020) (25)
[Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis]. (2006) (25)
High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension (2006) (25)
Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy. (1998) (25)
Corticotropin-releasing hormone, its binding protein and receptors in human cervical tissue at preterm and term labor in comparison to non-pregnant state (2006) (25)
Proopiomelanocortin-related peptides and methionine enkephalin in human follicular fluid: Changes during the menstrual cycle (1987) (25)
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. (1986) (25)
Paracrine/autocrine control of female reproduction (2000) (25)
Fetomaternal Opioid Levels and Parturition (1983) (25)
Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety. (2001) (25)
Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal and pathological pregnancies. (1997) (25)
Follistatin-related gene expression, but not follistatin expression, is decreased in human endometrial adenocarcinoma. (2004) (24)
Expression of prolactin-releasing peptide and its receptor in the human decidua. (2002) (24)
Reduced spinal bone density in young women with amenorrhoea. (1991) (24)
General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy (2001) (24)
A randomized controlled study comparing carbon dioxide versus normal saline as distension media in diagnostic office hysteroscopy: is the distension with carbon dioxide a problem? (2010) (24)
Indication of prophylactic vaccines as a tool for secondary prevention in HPV-linked disease (2018) (24)
Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis. (2007) (24)
Nonsurgical Alternatives for Uterine Fibroids. (2016) (24)
Human endometrium and decidua express follistatin-related gene (FLRG) mRNA and peptide (2004) (24)
Lack of β-Endorphin and β-Lipotropin Circadian Rhythmicity in Episodic Cluster Headache: A Model for Chronopathology (1985) (24)
Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery. (2007) (24)
Morphogenesis of human endothelial cells is inhibited by DAB2 via Src (2008) (24)
Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea. (1993) (24)
Plasma beta-endorphin levels in anovulatory states: changes after treatments for the induction of ovulation. (1986) (24)
Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. (1998) (24)
Altered expression of activin, cripto, and follistatin in the endometrium of women with endometrioma. (2011) (24)
Metformin Treatment is Effective in Obese Teenage Girls With PCOS (2007) (23)
Lack of correlation between amniotic fluid and maternal plasma contents of beta-endorphin, beta-lipotropin, and adrenocorticotropic hormone in normal and pathologic pregnancies. (1984) (23)
Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial (2017) (23)
Plasma opioids in the newborn in relation to the mode of delivery. (1986) (23)
Neuroendocrine evaluation of central opiate activity in primary headache disorders (1988) (23)
The brain : source and target for sex steroid hormones : 1st Tuscania Conference on Reproductive Medicine (1996) (23)
Neuroendocrine and stress-related aspects of endometriosis. (2015) (23)
Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death. (1999) (23)
Expression of proopiomelanocortin-related peptides in human follicular fluid (1988) (23)
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen. (2009) (23)
Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa (2012) (22)
Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts. (1985) (22)
Evaluation of endometrial activin A secretion for prediction of pregnancy after intrauterine insemination. (2010) (22)
Difference of LH and FSH secretory characteristics and degree of concordance between postmenopausal and aging women. (1997) (22)
Low serum concentrations of di-(2-ethylhexyl)phthalate in women with uterine fibromatosis (2006) (22)
Estrogen Changes as a Critical Factor in Modulation of Central Opioid Tonus: Possible Correlations with Post-Menopausal Migraine (1985) (22)
Validation of Italian version of the Women's Health Questionnaire: assessment of quality of life of women from the general population and those attending menopause centers (2002) (22)
Umbilical endometriosis in pregnancy: a case report (2004) (22)
Histologic chorioamnionitis at term: implications for the progress of labor and neonatal wellbeing (2013) (22)
Reduced ACTH, while normal β-endorphin CSF levels in early epileptic encephalopathies (1985) (21)
Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise (1990) (21)
Steroid-protein interaction in human placenta (1995) (21)
Dexamethasone fails to suppress hyperendorphinaemia of obese children. (1987) (21)
Hormonal treatments modulate pulsatile plasma growth hormone, gonadotrophin and osteocalcin levels in postmenopausal women. (1993) (21)
OESTRADIOL/PROGESTERONE IMBALANCE AND THE PREMENSTRUAL SYNDROME (1983) (21)
Spontaneous episodic release of adenohypophyseal hormones in hypothalamic amenorrhea. (1995) (21)
Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment. (2008) (21)
Placental neurohormones: secretion and physiological implications (1991) (21)
γ-Aminobutyric Acid Inhibits β-Endorphin Secretion from the Anterior Pituitary but not the Neurointermediate Lobe in the Rat (1986) (20)
Lack of beta-endorphin plasma level rise in oxytocin-induced labor. (1985) (20)
Antagonism by pivagabine of stress-induced changes in GABAA receptor function and corticotropin-releasing factor concentrations in rat brain (1999) (20)
Progressive impairment of CSF beta-EP levels in migraine sufferers. (1984) (20)
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score (2021) (20)
Expression of microtubule associated protein 2 and synaptophysin in endometrium: high levels in deep infiltrating endometriosis lesions. (2016) (20)
Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states. (1987) (20)
Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in vitro studies (2012) (20)
Ontogeny of pituitary beta-endorphin and related peptides in the human embryo and fetus. (1987) (20)
CSF and plasma levels of pro-opiomelanocortin-related peptides in reversible ischaemic attacks and strokes. (1986) (20)
Corticotropin-releasing factor-binding protein: origins and possible functions. (1996) (20)
Levels of Maternal Plasma Corticotropin-Releasing Factor and Urocortin During Labor (2002) (20)
Maternal position during non-stress test and fetal heart rate patterns. (2005) (20)
Role of the Retinoblastoma Family in Gynecological Cancer (2003) (20)
Sex Steroid Hormones and Reproductive Disorders (2011) (20)
Activin A, Activin Receptor Type II, Nodal, and Cripto mRNA Are Expressed by Eutopic and Ectopic Endometrium in Women With Ovarian Endometriosis (2009) (20)
Low-dose spinal anesthesia with hyperbaric bupivacaine with intrathecal fentanyl for operative hysteroscopy: a case series study. (2012) (20)
Labor (Term and Preterm) Is Associated With Changes in the Placental mRNA Expression of Corticotrophin-Releasing Factor (2007) (20)
Expression Levels of Myostatin and Matrix Metalloproteinase 14 mRNAs in Uterine Leiomyoma are Correlated With Dysmenorrhea (2015) (19)
Interleukin 1β and Progesterone Stimulate Activin A Expression and Secretion From Cultured Human Endometrial Stromal Cells (2007) (19)
The placenta as a neuroendocrine organ. (2001) (19)
Increased Response of Plasma Allopregnanolone to Corticotropin-Releasing Hormone in Obese Patients (2002) (19)
Is Stress a Cause or a Consequence of Endometriosis? (2020) (19)
Analysis of cell-cell junctions in human amnion and chorionic plate affected by chorioamnionitis. (2016) (19)
Beta-endorphin, beta-lipotropin and adrenocorticotropic hormone levels in cerebrospinal fluid, and brain damage in chronic alcoholics. (1983) (19)
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. (2021) (19)
Surgical treatment affects perceived stress differently in women with endometriosis: correlation with severity of pain. (2015) (19)
Polycystic ovary syndrome and type 2 diabetes mellitus. (2004) (19)
The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women (2010) (19)
Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions. (2016) (19)
A report of early (13 + 0 to 14 + 6 weeks) and mid-trimester amniocenteses: 10 years' experience (2003) (19)
FOXL2 in Human Endometrium (2014) (19)
Virtual Fetal Touch Through a Haptic Interface Decreases Maternal Anxiety and Salivary Cortisol (2005) (19)
Urocortin 2 Stimulates Estradiol Secretion From Cultured Human Placental Cells: An Effect Mediated by the Type 2 Corticotrophin-releasing Hormone (CRH) Receptor (2009) (18)
Histologic chorioamnionitis: different histologic features at different gestational ages (2014) (18)
Weight gain regardless of pre-pregnancy BMI and influence of fetal gender in response to labor induction in postdate pregnancy (2013) (18)
Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension. (2006) (18)
S100B protein increases in human blood and urine during stressful activity (2010) (18)
Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia (2009) (18)
Ovarian psammocarcinoma with peritoneal implants. (2003) (18)
Cervical ripening and induction of labor by prostaglandin E2: a comparison between intracervical gel and vaginal pessary (2003) (18)
Placenta expresses anti-Müllerian hormone and its receptor: Sex-related difference in fetal membranes. (2015) (18)
Central deficiency of beta-endorphin in alcohol addicts. (1982) (18)
Expression of Nodal, Cripto, SMAD3, Phosphorylated SMAD3, and SMAD4 in the Proliferative Endometrium of Women With Endometriosis (2015) (18)
Inhibins as diagnostic markers in human reproduction. (2008) (18)
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea (2001) (18)
Impaired beta-endorphin response to human corticotropin-releasing hormone in obese children. (1988) (18)
Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density (2003) (18)
Localization and expression of the three opioid systems. (1987) (18)
Hysteroscopic Endometrial Resection Versus Laparoscopic Supracervical Hysterectomy for Abnormal Uterine Bleeding: Long-term Follow-up of a Randomized Trial. (2015) (18)
Maternal decidua and fetal membranes contain immunoreactive neuropeptide Y (1993) (18)
Anterior placental location influences onset and progress of labor and postpartum outcome. (2015) (18)
Hemodynamic effect of danazol therapy in women with uterine leiomyomata. (2003) (18)
Present and future of recombinant gonadotropins in reproductive medicine. (2012) (18)
Identification of Activin A and Follistatin in Human Milk (2002) (18)
Endometriosis and Perceived Stress: Impact of Surgical and Medical Treatment (2015) (18)
Neurobehavioral and neurochemical abnormalities of pre- and postnatally lead-exposed rats: zinc, copper and calcium status. (1985) (17)
A new approach to the management of ovarian endometrioma to prevent tissue damage and recurrence. (2016) (17)
Adolescent Preeclampsia: Pathological Drivers and Clinical Prevention (2018) (17)
Functional opioid activity variates according to the different fashion of alcohol abuse. (1984) (17)
Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children (2003) (17)
CSF β-EP in Headache and Depression (1985) (17)
Opioid plasma levels in primary affective disorders. Effect of desimipramine therapy. (1984) (17)
Thickness of fetal membranes: a possible ultrasound marker for preterm delivery (2008) (17)
Abruptio placentae and highest maternal serum activin A levels at mid-gestation: a two cases report. (2003) (17)
Specific concordance index defines the physiological lag between LH and progesterone in women during the midluteal phase of the menstrual cycle. (1991) (17)
Expression of Matrix Metalloproteinases and Their Inhibitors in Endometrium: High Levels in Endometriotic Lesions (2020) (17)
The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester. (2007) (17)
The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome (2003) (16)
Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: roles of body weight and estrogen levels. (2001) (16)
The Cardiovascular Risk Factor Homocysteine Is Not Elevated in Young Women with Hyperandrogenism or Hypoestrogenism (2002) (16)
High levels of serum allopregnanolone in women with premature ovarian failure. (1998) (16)
Is fetal analgesia necessary during prenatal surgery? (2018) (16)
No gradient exists between lumbar and ventricular cerebrospinal fluid β-endorphin (1987) (16)
Prenatal ultrasonographic diagnosis of diastrophic dysplasia at 13 weeks of gestation (2003) (16)
High basal serum allopregnanolone levels in overweight girls (2007) (16)
Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss (1998) (16)
Chronic Pelvic Pain and Quality of Life in Women with and without Endometriosis (2013) (16)
Fetal Gender Effects on Induction of Labor in Postdate Pregnancies (2013) (16)
Polycystic ovary syndrome: it is always bilateral? (1999) (16)
Activin βA subunit, follistatin and follistatin-like 3 are expressed in the endometrium of ovariectomized rats and regulated by estrogen replacement (2008) (16)
Aging brain and dementias: changes in central opioids. (1988) (16)
Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better? (2020) (16)
Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation. (2010) (16)
Definition, prevalence, clinical relevance and treatment of T‐shaped uterus: systematic review (2020) (16)
Uterine fibroids affect pregnancy outcome in women over 30 years old: role of other risk factors (2013) (16)
Norgestimate increases pituitary and hypothalamic concentrations of immunoreactive beta-endorphin. (1989) (15)
Effect of oral contraceptives or dexamethasone on plasma beta-endorphin during the menstrual cycle. (1989) (15)
Influence of non-gonadotrophic hormones on gonadal function (2000) (15)
CHAPTER 53 – Placental Endocrine Function (2006) (15)
Pregnancy following combined growth hormone--pulsatile GnRH treatment in a patient with hypothalamic amenorrhoea. (1990) (15)
Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. (2008) (15)
Overweight and lower age at menarche: evidence from the Italian HBSC cross-sectional survey (2018) (15)
Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation (1986) (15)
Plasma beta-endorphin in response to oral glucose tolerance test in obese patients. (1987) (15)
Lack of gestation-related changes of urocortin gene expression in human placenta (1999) (15)
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome. (2000) (15)
The Increase of Blood Flow in the Fetal Middle Cerebral Artery Correlates With the Onset of Labor at Term (2008) (15)
Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer (2018) (15)
UROCORTIN STIMULATES PLACENTAL ADRENOCORTICOTROPIN AND PROSTGLANDIN RELEASE AND MYOMETRICAL CONCTRACTILY (1999) (15)
Twin pregnancies after assisted reproductive technologies: the role of maternal age on pregnancy outcome. (2016) (15)
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women. (1997) (15)
Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans. (1996) (15)
Activin A and Follistatin in Menstrual Blood: Low Concentrations in Women With Dysfunctional Uterine Bleeding (2007) (15)
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea (2014) (15)
Ultrasound findings in infertile women with endometriosis: evidence of concomitant uterine disorders (2020) (15)
Acute beta-interferon or thymopentin administration increases plasma growth hormone and cortisol levels in children. (1992) (15)
Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women (1998) (15)
Dysmenorrhea and Heavy Menstrual Bleeding in Elite Female Athletes: Quality of Life and Perceived Stress (2020) (15)
Anti-inflammatory effects of androgens in the human vagina. (2020) (14)
Opioid Control of Gonadotropin Secretion (1990) (14)
Amniotic fluid and umbilical cord plasma corticotropin-releasing factor (CRF), CRF-binding protein, adrenocorticotropin, and cortisol concentrations in intraamniotic infection and inflammation at term. (2008) (14)
Activin A and its Regulatory Molecules in Placenta and Fetal Membranes of Women with Preterm Premature Rupture of the Membranes Associated with Acute Chorioamnionitis (2012) (14)
Management of sexual dysfunctions in women. (2003) (14)
Indication of hysteroscopy in tamoxifen treated breast cancer patients. (2002) (14)
Peripartum and postpartum outcomes in uncomplicated term pregnancy following ART: a retrospective cohort study from two Italian obstetric units (2018) (14)
Corticotropin-releasing factor, urocortin and endothelin-1 stimulate activin A release from cultured human placental cells. (2002) (14)
Endocrine role of the placenta and related membranes. (1996) (14)
Cerebrospinal fluid corticotropin‐releasing factor levels and stimulation test in dementia of the alzheimer type (1990) (14)
Maternal anemia effects during pregnancy on male and female fetuses: are there any differences? (2017) (14)
The Influence of Doctor-Patient and Midwife-Patient Relationship in Quality Care Perception of Italian Pregnant Women: An Exploratory Study (2015) (14)
Levels of Maternal Plasma Corticotropin-Releasing Factor and Urocortin During Labor: (2002) (14)
Reduced Maternal Plasma Urocortin Concentrations and Impaired Uterine Artery Blood Flow at Human Mid Pregnancy (2005) (14)
Expression of betaglycan in pregnant tIssues throughout gestation. (2003) (14)
Serum Inhibin B Correlates with Successful Ovulation in Infertile Women (2003) (14)
Reduction of steps in the preparation of motile sperm for intrauterine insemination does not reduce efficacy of the procedure: simplified one-step swim-up method versus classic swim-up. (2002) (14)
Surgical treatment of endometriosis: prognostic factors for better quality of life (2019) (14)
Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women (2018) (13)
Influence of assisted reproductive technologies on maternal and neonatal outcomes in early preterm deliveries. (2019) (13)
Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation. (2006) (13)
Plasma endorphins in Rett syndrome: preliminary data. (1986) (13)
Ritanserin, a Serotonin-S2 Receptor Antagonist, Does Not Prevent 5-Hydroxytryptophan-Induced β-EP, β-LPH and Cortisol Secretion (1987) (13)
Small thymus at birth and gestational age (2002) (13)
Neuroendocrine Correlates of Stress‐Related Amenorrhea (1991) (13)
The safety of veralipride (2006) (13)
beta-Endorphin and beta-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disorders. (1981) (13)
Plasma β-endorphin, free fatty acids and blood lipid changes in type 2 (non-insulin dependent) diabetic patients (1988) (13)
Ultrasound estimated fetal weight slightly below the median is associated with increased risk of spontaneous preterm birth (2012) (13)
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans. (1993) (13)
Genes involved in the pathogenesis of premature ovarian insufficiency. (2015) (13)
Risk of low bone density in women attending menopause clinics in Italy (2002) (13)
Effects of cyproheptadine clorhydrate ,a serotonin receptor antagonist ,on endocrine parameters in weight-loss related amenorrhea (2001) (13)
Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin. (1988) (12)
Is an excessive number of prenatal echographies a risk for fetal growth? (2005) (12)
Changes in β‐Endorphin in Fetal Membranes and Placenta in Normal and Pathological Pregnancies (1990) (12)
Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β-induced fibrosis. (2020) (12)
Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhoea (1993) (12)
Serum Markers for the Noninvasive Diagnosis of Endometriosis (2015) (12)
Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition. (2015) (12)
Evaluation of endometrial urocortin secretion for prediction of pregnancy after intrauterine insemination. (2008) (12)
Evidence suggesting an additional control mechanism regulating episodic secretion of luteinizing hormone and follicle stimulating hormone in pre-pubertal children and post-menopausal women. (1994) (12)
Correlation With Placental Kisspeptin in Postterm Pregnancy and Apoptosis (2012) (12)
Contraception as prevention and therapy: sex steroids and the brain. (1998) (12)
High serum allopregnanolone levels in girls with precocious puberty. (2002) (12)
Re‐evaluation of risk for Down syndrome by means of the combined test in pregnant women of 35 years or more (2005) (12)
Dysregulation of plasma pro-opiomelanocortin-related peptides in neurotic depression. (1986) (12)
Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. (1988) (12)
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids (1985) (12)
Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women (2001) (12)
The role of the placenta in fetal programming (2014) (12)
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study (2021) (12)
Non-contraceptive benefits of intrauterine levonorgestrel administration: why not? (2017) (12)
Amniotic fluid urocortin, CRF, oestriol, dehydroepiandrosterone sulfate and cortisol concentrations at mid-trimester: putative relationship with preterm delivery. (2009) (12)
Insight on the intracrinology of menopause: androgen production within the human vagina. (2020) (12)
Interleukin 1beta and progesterone stimulate activin a expression and secretion from cultured human endometrial stromal cells. (2007) (12)
Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells. (2016) (12)
Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. (1987) (11)
Serum activin A levels are lower in tubal than intrauterine spontaneously conceived pregnancies (2011) (11)
Corticotrophin-releasing factor and urocortin inhibit system A activity in term human placental villous explants. (2011) (11)
Abnormal dexamethasone suppression test in daily chronic headache sufferers (1986) (11)
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. (1990) (11)
Epidemiology of early pre-term delivery: Relationship with clinical and histopathological infective parameters (2013) (11)
The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis (2022) (11)
Growth hormone (GH)-releasing hormone-induced GH response in hypothalamic amenorrhea: evidence of altered central neuromodulation. (1996) (11)
Listeriosis in pregnancy: A case report (2005) (11)
Human GnRH-secreting cultured neurons express activin betaA subunit mRNA and secrete dimeric activin A. (2000) (11)
Effect of activin A on tumor necrosis factor-alpha/intercellular adhesion molecule-1 pathway in endometrial stromal cells. (2005) (11)
Serum activin A levels in males and females during pubertal development. (2001) (11)
Hypothalamic amenorrhea: Neuroendocrine mechanisms / stress-induced anomalies (1997) (11)
Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma. (2002) (11)
Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations. (1998) (11)
Placental neurokinin B mRNA expression increases at preterm labor. (2007) (11)
Preterm Birth: Mechanisms, Mediators, Prediction, Prevention & Interventions (2007) (11)
Plasma B-endorphin resistance to dexamethasone suppression in obese patients (1988) (11)
Increased expression of neurogenic factors in uterine fibroids. (2019) (11)
Maternal serum protein S forms in pregnancies complicated by intrauterine growth restriction. (2012) (11)
Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans. (1984) (11)
Clinical outcomes associated with surgical treatment of endometrioma coupled with resection of the posterior broad ligament (2012) (11)
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives. (2001) (11)
Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women. (2001) (11)
Age at menarche does not correlate with the endometriosis phenotype (2019) (11)
Birth, Distress and Disease: Placental expression of neurohormones and other neuroactive molecules in human pregnancy (2005) (11)
Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women. (2002) (11)
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men (1994) (11)
Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortions. (2007) (11)
Mutational analysis of the inhibin alpha gene in preeclamptic women (2005) (11)
An Ovarian Mucinous Adenocarcinoma Arising from Mature Cystic Teratoma Associated with Respiratory Type Tissue: A Case Report (2004) (11)
Parenterally administered moderate sedation and paracervical block versus general anesthesia for hysteroscopic polypectomy: a pilot study comparing postoperative outcomes. (2015) (10)
Clinical implications of circulating neurosteroids. (2001) (10)
Food related risks during pregnancy: how much do women know about it? (2014) (10)
Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol (2007) (10)
Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone) (2019) (10)
Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women. (2003) (10)
Episodic release of prolactin in women with weight loss-related amenorrhea. (1994) (10)
Dienogest Treatment Improves Quality of Life in Women with Endometriosis (2015) (10)
Deep Infiltrating Endometriosis and Endometrial Adenocarcinoma Express High Levels of Myostatin and Its Receptors Messenger RNAs (2017) (10)
Opioid regulation of luteinizing hormone in amenorrheic patients after therapy for induction of ovulation. (1987) (10)
Bilateral Endometrioma Excision: Surgery-Related Damage to Ovarian Reserve (2018) (10)
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials (2022) (10)
Endometrial expression of relaxin and relaxin receptor in endometriosis. (2010) (10)
The International Society of Gynecological Endocrinology and its President (2012) (10)
New protocol of clomiphene citrate treatment in women with hypothalamic amenorrhea (2007) (10)
Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations (2000) (10)
SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction (2021) (10)
Proopiomelanocortin‐related peptides and methionine enkephalin in human follicular fluid: Changes during the menstrual cycle (1988) (10)
Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women (1992) (10)
Factor II: C activity and uterine artery Doppler evaluation to improve the early prediction of pre-eclampsia on women with gestational hypertension (2005) (10)
Human endometrium expresses urocortin II and III messenger RNA and peptides. (2006) (10)
Circulating Levels of Allopregnanolone, a Neuroactive Steroid, and Leptin during Treatment with Valproic Acid in Children with Epilepsy (2010) (10)
Changes in immunoreactive beta-endorphin, methionine-enkephalin and ACTH in bone marrow cells and fluid from leukemic children. (1986) (10)
High Concentrations of Activin A in the Peritoneal Fluid of Women With Epithelial Ovarian Cancer (2004) (10)
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea (2000) (9)
Molecular pathology of ovarian cancer. (2005) (9)
Serum activin A levels in males and females during pubertal development (2001) (9)
Hormone replacement therapy in menopause and in premature ovarian insufficiency. (2013) (9)
The identification of high risk pregnancy: a new challenge in obstetrics (2012) (9)
Different patterns of central and peripheral beta EP, beta LPH and ACTH throughout life. (1983) (9)
Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women (1992) (9)
Serum inhibin A, inhibin B, and pro-alphaC levels are altered after surgically or pharmacologically induced menopause. (2002) (9)
Prostaglandin-induced mid-pregnancy abortion increases plasma and amniotic fluid levels of beta-lipotropin and beta-endorphin. (1987) (9)
Presence of Acetylated and Shortened Endorphins in Human Fetal Pituitary Gland (1989) (9)
Long-Term Vaginal Danazol Treatment in Fertile Age Women with Adenomyosis (2017) (9)
Cycle Control and Bleeding Pattern of a 24/4 Regimen of Drospirenone 3 mg/Ethinylestradiol 20 μg Compared with a 21/7 Regimen of Desogestrel 150 μg/Ethinylestradiol 20 μg (2011) (9)
The effect of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive‐aged women (1991) (9)
High concentrations of inhibin A and inhibin B in ovarian serous cystadenoma: relationship with oestradiol and nitric oxide metabolites. (2000) (9)
Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells. (2020) (9)
Serum tryptophan and 5-hydroxytryptophan at birth and during post-partum days. (2003) (9)
Effects of neuroleptic treatments on peripheral opioid secretion. (1987) (9)
Pharmacologic treatment of the ovarian endometrioma (2016) (9)
Treatment of androgen excess in females: yesterday, today and tomorrow. (1997) (9)
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women. (1987) (8)
Acetyl-l-carnitine restores the daily pattern of hypothalamic beta-endorphin in rats exposed to continuous light. (1990) (8)
Menopause, the Cardiovascular Risk Factor Homocysteine, and the Effects of Treatment (2004) (8)
Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women (2006) (8)
Neuromodulatory Role of Opioidergic System on Hypothalamus—Pituitary—Gonadal Axis during Puberty (1997) (8)
Naproxen sodium decreases prostaglandins secretion from cultured human endometrial stromal cells modulating metabolizing enzymes mRNA expression (2016) (8)
The Use of a Combined Regimen of GnRH Agonist Plus a Low-Dose Oral Contraceptive Improves the Spontaneous Pulsatile LH Secretory Characteristics in Patients with Polycycstic Ovary Disease After Discontinuation of Treatment (2000) (8)
Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study. (2019) (8)
Abnormal beta-endorphin and beta-lipotropin responses to TRH and LRH administration in primary and secondary affective disorders. (1986) (8)
Adrenergic and serotoninergic receptors mediate the immunological activation of corticosterone secretion in male rats. (1996) (8)
Current and Future Medical Treatment of Adenomyosis (2016) (8)
Neuroendocrine mechanisms regulating placental hormone production. (1991) (8)
Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women (2001) (8)
Acetyl‐1‐carnitine as possible drug in the treatment of hypothalamic amenorrhea (1991) (8)
Episodic changes of serum procollagen type I carboxy-terminal propeptide levels in fertile and postmenopausal women. (1994) (8)
Yolk sac tumor in a young girl: A case report (2005) (8)
Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration. (2007) (8)
Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms (2021) (8)
Acetyl‐L‐Carnitine Effect on Pituitary and Plasma β‐Endorphin Responsiveness to Different Chronic Intermittent Stressors (1993) (8)
Low serum allopregnanolone levels in girls with precocious pubarche (2005) (8)
Long-term hormonal treatment reduces repetitive surgery for endometriosis recurrence. (2020) (8)
Plasma β-endorphin levels in obese and non-obese patients with polycystic ovarian disease (1989) (7)
Inhibin A ,inhibin B and activin A concentrations in umbilical cord artery and vein (2003) (7)
β-Endorphin in Human Reproduction (1993) (7)
Control of growth hormone secretion during the postpartum period. (1992) (7)
Dermorphin Reduces the Metyrapone-Evoked Release of Adrenocorticotropin, β-Endorphin, and β-Lipotropin in Man** (1985) (7)
An informative probability model enhancing real time echobiometry to improve fetal weight estimation accuracy (2008) (7)
Expression and regulation of 11β-hydroxysteroid dehydrogenase type 1 in first trimester human decidua cells: Implication in preeclampsia (2016) (7)
Central and peripheral beta-endorphin response to transcutaneous electrical nerve stimulation. (1986) (7)
Urocortin 1 expression and secretion by human umbilical vein endothelial cells: In vitro effects of interleukin 8, interferon γ, lipopolysaccharide, endothelin 1, prostaglandin F-2α, estradiol, progesterone and dexamethasone (2015) (7)
PROOPIOCORTIN-RELATED PEPTIDES IN AGING (1981) (7)
Acetyl-L-carnitine acutely administered raises beta-endorphin and cortisol plasma levels in humans. (1988) (7)
Reduction of beta-endorphin levels in the amniotic fluid of heroin addicts. (1986) (7)
Endogenous opioid inhibitory tone on LH secretion in normal puberty and in several pubertal disturbances. (1986) (7)
Estrous cycle- and acute stress-related changes of rat ovarian immunoreactive corticotropin-releasing factor. (1996) (7)
Menopause, depression, and plasma opioids. (1982) (7)
11β-hydroxysteroid dehydrogenase type 1 and pregnancy: Role in the timing of labour onset and in myometrial contraction (2017) (7)
Perinatal outcomes of pregnant women with severe COVID-19 requiring extracorporeal membrane oxygenation (ECMO): a case series and literature review (2022) (7)
Circulating beta–endorphin levels at various stages of life: possible connections with migraine pathogenesis (1983) (7)
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? (2020) (6)
Physical Activity and Female Sexual Dysfunction: A Lot Helps, But Not Too Much. (2021) (6)
High Levels of Human Chromogranin A in Umbilical Cord Plasma and Amniotic Fluid at Parturition (2002) (6)
Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction (2021) (6)
Local drug release systems in endometriosis (2007) (6)
Corticotropin releasing hormone and Urocortin 2 activate inflammatory pathways in cultured trophoblast cell lines. (2015) (6)
N‐terminal ACTH fragments increase the CSF β‐EP content in Alzheimer type dementia (1988) (6)
Premenstrual fall of plasma beta-endorphin in patients with premenstrual syndrome. (1987) (6)
Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas. (2021) (6)
Circadian variations of proopiocortin-related peptides in children with migraine (1983) (6)
Progestins for the Treatment of Endometriosis: An Update: (2010) (6)
Management of fibroids in perimenopausal women (2015) (6)
Prevention and management of preterm labour (2009) (6)
Endometriosis – Pathogenesis, Diagnosis, and Therapeutic Options for Clinical and Ambulatory Care (2013) (6)
Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons (1987) (6)
Placental Stress Factors and Human Parturition (1997) (6)
Secretion and Putative Role of Activin and CRF in Human Parturition a (1994) (6)
GH, IGFBP-1, and IGFBP-3 response to oral glucose tolerance test in perimenopausal women: no influence of body mass index. (1999) (6)
Autonomous beta-endorphin secretion from the pituitary neurointermediate lobe: in vivo studies. (1984) (6)
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women (2004) (6)
Beta-endorphin response to oral glucose tolerance test in obese and non-obese pre- and postmenopausal women. (1998) (6)
Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy. (2007) (6)
Immune-neuroendocrine correlations: a new aspect in human physiology. (1991) (6)
Inflammatory and infectious risk factors are associated with the response to tocolysis in patients with preterm labor (2011) (6)
Serum levels of inhibin B in adolescents after varicocelelectomy: A long term follow up (2016) (6)
Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia. (1987) (5)
[Use of domperidone in the induction and maintenance of maternal breast feeding]. (1986) (5)
Uterine fibroid vascularization: from morphological evidence to clinical implications (2021) (5)
Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect. (2021) (5)
Enhancing Medical Device Training with Hybrid Physical-Virtual Simulators: Smart Peripherals for Virtual Devices (2013) (5)
Relaxin in Endometriosis (2009) (5)
Congenital Uterine Malformation by Experts (CUME): T-shaped uterus (2019) (5)
Is primary dysmenorrhea a precursor of future endometriosis development? (2021) (5)
Neuroendocrinology of the Menstrual Cycle (1997) (5)
Beta-endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women. (1985) (5)
CSF beta-EP in headache and depression. (1985) (5)
Oral Contraceptives after Myomectomy: A Short Term Trial (2009) (5)
Different Gestational Diabetes Phenotypes: Which Insulin Regimen Fits Better? (2021) (5)
Evaluation of central opioid tonus in menstrual migraine (1983) (5)
Post-ictal circulating levels of allopregnanolone in children with partial or generalized seizures (2005) (5)
Inflammation calls for more: Severe pelvic inflammatory disease with or without endometriosis. Outcomes on 311 laparoscopically treated women. (2020) (5)
Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8–9, 2007 (2007) (5)
[Noradrenaline and interleukin-1 stimulate CRF secretion from human placental cells in culture]. (1988) (5)
Failure of Central Opioid Tonus in Migraine: Modulation of Steroid Milieu (1985) (5)
Faculty Opinions recommendation of Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition. (2019) (5)
Ultrasound diagnosis and Doppler monitoring of a pelvic spleen in pregnancy (2001) (5)
Attenuated Tubal and Endometrial Urocortin 1 and Corticotropin-Releasing Hormone Receptor Expression in Ectopic Pregnancy (2011) (5)
Classification/staging systems for endometriosis: the state of the art (2020) (5)
Cardiac arrest in the delivery room after spinal anesthesia for cesarean section: a case report and review of literature (2018) (5)
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature. (2020) (5)
Beta-lipotropin is the major component of the plasma opioid response to surgical stress in humans. (1987) (5)
Opioids II (1993) (5)
Omega 3 Fatty Acids Counteract IL-8 and Prostaglandin E2 Secretion Induced by TNF-α in Cultured Endometrial Stromal Cells (2011) (5)
Puerperal breast feeding does not stimulate circulating opioids in humans (1982) (5)
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. (2004) (5)
Evaluation of umbilical cord pulsatility after vaginal delivery in singleton pregnancies at term. (2019) (5)
Role of endometriosis in defining cardiovascular risk: a gender medicine approach for women’s health (2021) (5)
Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. (1989) (5)
Intrauterine volvulus with malrotation: prenatal diagnosis. (2013) (5)
Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes (2010) (4)
Ongoing mother-to-child transmission of Chagas disease in Italy: 2014-2018 estimates. (2020) (4)
Expression and Role of Peptides, Proteins and Growth Factors in the Pathogenesis of Endometriosis (2009) (4)
Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives (2004) (4)
Consumerism in Prenatal Diagnosis? A Local Italian Study (2008) (4)
Involvement Of Serotonin In The Central Control Of Opioid Secretion (1987) (4)
Extent of bile acid-induced hepatic damage dictates activin a secretion in HepG2 cells (2000) (4)
Endocrine response to superovulatory treatment in pre-pubertal beef heifers: its lack of ability to induce puberty (1988) (4)
The FeTouch project: an application of haptic technologies to obstetrics and gynaecology (2004) (4)
Undifferentiated Connective Tissue Disease in Pregnancy: A Topic Yet to be Explored (2022) (4)
Pituitary-adrenal function and cognitive performance in demented patients on acetyl-L-carnitine treatment (1993) (4)
Fetal neural tube defects: maternal serum and amniotic fluid activin A levels (2004) (4)
Impairment of dopaminergic and opioidergic activity in patients with polycystic ovarian disease is restored by treatment for the induction of ovulation. (1989) (4)
Perspectives on stress-induced amenorrhea (1991) (4)
Low Molecular Weight Heparins (LMWH) and Implications along Pregnancy: a Focus on the Placenta (2021) (4)
Quantitative determination of sst2 and sst5 gene expression in uterine leiomyomata and the effect of treatment with somatostatin analogue. (2003) (4)
Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy. (1989) (4)
Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty. (2011) (4)
Impaired Uterine Artery Blood Flow at Mid Gestation and Low Levels of Maternal Plasma Corticotropin-Releasing Factor (2003) (4)
Regression of ovarian enlargement in pharmacological ovulation induction (2001) (4)
Faculty Opinions recommendation of Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. (2019) (4)
Progesterone and Progestins Modulate Hypothalamic and Pituitary β-Endorphin (1988) (4)
Women’s attitude toward gynecological pain in fertile age: Results from a cross-sectional study among Italian community pharmacies (2018) (3)
Pituitary and ovarian interleukin-1 alpha content changes according to estrous cycle and acute stress exposure. (1994) (3)
Human Placental Corticotropin-releasing Factor (CRF) in the Adaptive Response to Pregnancy (2001) (3)
CHRONIC MATERNAL PRENATAL STRESS AND NEONATAL DEVELOPMENT : EXPERIMENTAL STUDY (1995) (3)
Review: Human Reproduction in Art: From Myths to History (2010) (3)
188 LH RESPONSES TO NALOXONE IN NORMAL PRECOCIOUS AND DELAYEO PUBERTY (1985) (3)
44 Oxidative Stress in Amniotic Fluid of Pregnancies with Fetal Growth Retardation (2004) (3)
Abnormal uterine bleeding unrelated to structural uterine abnormalities: management in the perimenopausal period. (2017) (3)
Hormonal drugs for the treatment of endometriosis. (2022) (3)
Surgical Treatment Affects Perceived Stress Differently in Women With Endometriosis: Correlation With Severity of Pain. (2015) (3)
Ovary and ultrasound: from physiology to disease (2012) (3)
Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy (1998) (3)
Human leukocyte antigen DQ2/DQ8 positivity in women with history of stillbirth (2018) (3)
Expression, localization and control of activin A release from human umbilical vein endothelial cells (2015) (3)
beta-Endorphin modulates the inhibitory action of corticotropin-releasing factor on luteinizing hormone secretion. (1986) (3)
Human Reproduction Update: double digits and beyond. (2016) (3)
Polyhydramnios: a predictor of severe growth impairment in achondroplasia. (2002) (3)
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis. (2019) (3)
Managing fetal growth restriction: surveillance tests and their interpretation. (2019) (3)
High levels of intrauterine corticotrophin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. (2003) (3)
High levels of human Chromogranin A in umbilical cord plasma and amniotic fluid at parturition. (2002) (3)
Intrinsic secretory characteristics of luteinizing hormone and prolactin episodic release during pubertal development. (1994) (3)
The impact of assisted reproductive technology on prenatally diagnosed fetal growth restriction in dichorionic twin pregnancies (2020) (3)
Clinical use of placental hormones in pregnancymanagement (2012) (3)
Postdate pregnancy: changes of placental/membranes 11β-hydroxysteroid dehydrogenase mRNA and activity. (2013) (3)
Placental hormones and identification of pregnancy at risk (2010) (3)
Absent B-endorphin response to clonidine in obese children. (1988) (3)
Development of the Fetal Hypothalamic-Pituitary-Adrenal-Placental Axis: Implications for Postnatal Health (2009) (3)
Comorbidities and Quality of Life in Women Undergoing First Surgery for Endometriosis: Differences Between Chinese and Italian Population (2021) (3)
Ontogeny of the circadian rhythm in medial basal hypothalamic ß-endorphin content in female rat (1994) (3)
Estrogens as neuromodulators (1997) (2)
Emergency surgery for appendectomy and incidental diagnosis of superficial peritoneal endometriosis in fertile age women. (2020) (2)
The CROWN Initiative: journal editors invite researchers to develop core outcomes in women's health. (2014) (2)
New perspectives for the treatment of endometriosis (2012) (2)
Plasma beta-endorphin, free fatty acids and blood lipid changes in type 2 (non-insulin dependent) diabetic patients. (1988) (2)
Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge? (2012) (2)
Analysis of tight junctions in placentas affected by chorioamnionitis: in vivo and in vitro analysis (2012) (2)
W314 CARBETOCIN VERSUS OXYTOCIN AFTER CAESAREAN SECTION: SIMILAR EFFICACY BUT REDUCED PAIN PERCEPTION IN WOMEN WITH HIGH RISK OF POSTPARTUM HAEMORRHAGE (2012) (2)
Sphingosine 1-phosphate pathway is dysregulated in adenomyosis. (2022) (2)
Pituitary proopiomelanocortin peptides in mental disorders. (1986) (2)
P08.05: Intrauterine oxidative stress and Doppler flussimetry in fetuses with IUGR (2004) (2)
Faculty Opinions recommendation of A sonographic classification and reporting system for diagnosing adenomyosis. (2019) (2)
O-135 Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials (2021) (2)
Errors and pitfalls in reading the cardiotocographic tracing. (2019) (2)
Lack of clinical-EEG effects of naloxone injection on infantile spasms (1988) (2)
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases (2022) (2)
Abnormal Umbilical Artery Doppler Waveforms and Cord Blood Inhibin A and Inhibin B Levels (2003) (2)
From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health. (2022) (2)
Uterine fibroid: from pathogenesis to clinical management. (2016) (2)
Postpartum hemorrhage: not only hypertensive disorders in oocyte donation pregnancies. (2019) (2)
Placental and maternal serum activin A in spontaneous and induced labor in late-term pregnancy (2018) (2)
New epigenetic mechanism involved in leiomyoma formation. (2020) (2)
Urocortin in amniotic fluid and Down syndrome (2009) (2)
Advances in gynecological endocrinology (2012) (2)
Menstrual Distress Questionnaire (MEDI-Q): a new tool to assess menstruation-related distress. (2021) (2)
Global Pandemics, the Mother and Her Infant: Learning from the Past to Help the Future (2020) (2)
Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness. (2006) (2)
Fetal middle cerebral artery Doppler in late-term pregnancy: a predicting factor for failed induction of labor (2018) (2)
Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climacteric and postmenopausal women. (1985) (2)
Enhanced Endometriosis Archiving Software (ENEAS): An Application for Storing, Retrieving, Comparing, and Sharing Data of Patients Affected by Endometriosis Integrated in the Daily Practice. (2017) (2)
Iron deficiency anemia: Impact on women's reproductive health. (2022) (2)
Intrahepatic cholestasis of pregnancy – Time to redefine the reference range of total serum bile acids: A cross‐sectional study (2022) (2)
RKIP and cytotrophoblast motility (2012) (2)
Opioid Peptides in Fetal Membranes: Interferences of Maternal Opiate Addiction1 (1985) (2)
gamma-Aminobutyric acid inhibits beta-endorphin secretion from the anterior pituitary but not the neurointermediate lobe in the rat. (1986) (2)
Production and Putative Roles of Inhibins and Corticotropin-Releasing Factor in Human Placenta and Decidua (1991) (2)
Non-hormonal targets for the medical treatment of endometriosis (2012) (2)
The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study (2000) (2)
Maternal hemodynamic changes in gestational diabetes: a prospective case–control study (2021) (2)
Robotic treatment for urinary tract endometriosis: preliminary results and surgical details in a high-volume single-Institutional cohort study (2020) (2)
Long-term treatment of endometriosis-related pain among women seeking hormonal contraception (2022) (2)
Risk Factors for Gestational Diseases (2012) (2)
Activin A in newborns with and without hypoxia at birth (2002) (2)
Endometriosis: Cellular and Molecular Mechanisms Leading to Fibrosis (2022) (2)
Endogenous opioid system in acute myocardial infarction (1984) (1)
Maternal Plasma Calcitonin Gene-Related Peptide Levels Do Not Change During Labor and Are Not Influenced by Delivery Route (2001) (1)
Predicting Pregnancy after Surgery for Pelvic Endometriosis: A Multivariate Analysis Based on Objective Clinical Data (2010) (1)
Predictive factors of induction delivery failure (2014) (1)
METHODS OF PREDICTION AND PREVENTION (2007) (1)
P03.01: T‐shaped uterus by congenital uterine malformation by experts (CUME): interrater reliability of useful measurements (2019) (1)
Plasma β-endorphin levels in anovulatory states: changes after treatments for the induction of ovulation**Supported by the Consiglio Nazionale delle Ricerche. (1986) (1)
Beta-endorphins in essential blepharospasm (1994) (1)
Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan-induced beta-EP, beta-LPH and cortisol secretion. (1987) (1)
Maternal serum inhibin A measurement may predict the pregnancy outcome in women with threatened abortion (2003) (1)
Hormonal pulsatile release and computerized techniques for pulse detection (1991) (1)
Faculty Opinions recommendation of Complications and outcomes of pregnant women with adenomyosis in Japan. (2019) (1)
Mothers with HIP - The short term and long-term impact, what is new? (2018) (1)
OC29.04: T‐shaped uterus by Congenital Uterine Malformation by Experts (CUME): agreement of subjective assessment among top expert (2019) (1)
OC282: Amniotic fluid isoprostane levels in fetuses with cystic hygroma (2007) (1)
[Circulating opioid peptides in chronic renal failure: acute effect of dialysis treatment]. (1982) (1)
Ultrasound Evaluation of Localization of Pelvic Deep Infiltrating Endometriosis (DIE) and Correlation to Surgical Classifications (2012) (1)
P063 Estradiol or tibolone administration increases GH secretion in postmenopausal women (1996) (1)
Ovarian hyperstimulation-like syndrome after administration of triptorelin to a woman with endometriosis (2002) (1)
Proopiomelanocortin-related peptides in feto-placental structures throughout pregnancy. (2009) (1)
Stress Hormones, Human Pregnancy and Parturition (2001) (1)
Central Nervous System (1974) (1)
Prolactin Secretion After Surgery or Bromocriptine Treatment of Prolactinoma (1987) (1)
Efficacy and safety of slow release dinoprostone insert for induction of labor: correlation with parity. (2008) (1)
[Effect of cold stress on the concentrations in the hypothalamus, pituitary, and blood of beta-lipotropin and beta-endorphin in the rabbit]. (1981) (1)
The Menstrual Disorders Related to Systemic Diseases (2020) (1)
P052: Can a selective use of amniocentesis replace the routine for advanced maternal age? (2003) (1)
Adenomyosis, Endometrioma and Deep Infiltrating Endometriosis Their Mutual Prevalence and Symptoms Correlation (2013) (1)
Sperm chromosome aneuploidy and gonadotrophin treatment (2006) (1)
Reversible increase of serum activin A levels in women with Graves’ disease (2002) (1)
Interleukin-2 production by cultured human granulosa cells. (1997) (1)
Impact of bladder filling on uterine artery Doppler variables in the first trimester of pregnancy (2018) (1)
Author’s Response: Allopregnanolone Assays (2001) (1)
Clarification of scope for Human Reproduction and Molecular Human Reproduction†. (2015) (1)
Menstrual Cycle Related Disorders (2019) (1)
Cyproterone acetate as progestin in the treatment of climacteric disorders (1992) (1)
Advances in gynecological endocrinology : the proceedings of the plenary sessions of the 8th World Congress of Gynecological Endocrinology, Florence, Italy, December 2000 (2002) (1)
Dermorphin reduces the metyrapone-evoked release of adrenocorticotropin, beta-endorphin, and beta-lipotropin in man. (1985) (1)
Central Regulation of Circulating Beta-Endorphin: Possible Implication in Headache Treatments (1985) (1)
OVULATION AND STRESS: PATHOPHYSIOLOGY (1990) (1)
[Patients with functional hypothalamic amenorrhea are characterized by low serum inhibin B concentrations]. (2010) (1)
Progestins for the Treatment of Endometriosis: An Update (2010) (1)
PSYCHOIMMUNOENDOCRINE ASPECTS OF PANIC DISORDERS (1992) (1)
Incidence of Menstrual Disorders is Not Influenced by Nulliparity (2013) (1)
Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty (2011) (1)
Erratum to: Long-term reliability of fractioned CO2 laser as a treatment for vulvovaginal atrophy (VVA) symptoms (2017) (1)
Abnormal uterine bleeding unrelated to uterine structural abnormalities: management in the perimenopausal period (2016) (1)
Meet our new editor: ProfessorFelice Petraglia. (2019) (1)
Faculty Opinions recommendation of Primary dysmenorrhea magnitude, associated risk factors, and its effect on academic performance: evidence from female university students in Ethiopia. (2017) (1)
Adrenal steroid responses to naloxone in polycystic ovarian disease. (1987) (1)
Human sperm aneuploidy: FISH analysis in fertile and infertile men (2011) (1)
Faculty Opinions recommendation of The impact of adenomyosis on women's fertility. (2019) (1)
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women. (1998) (1)
Clarification of scope for Human Reproduction and Molecular Human Reproduction†. (2015) (1)
Gynaecologic and Systemic Comorbidities in Patients with Endometriosis: Impact on Quality of Life and Global Health (2022) (1)
Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia. (1985) (1)
Pregnancy and Delivery After Right Common Carotid Artery Endarterectomy (2004) (1)
From biology to biochemical and biophysical diagnostic tools of ovarian tumors (2001) (1)
Comorbidities, risk factors and maternal/perinatal outcomes in oocyte donation pregnancies. (2020) (1)
Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovarian disease. (1989) (1)
Fetal Stress: Ultrasound Study of Fetal Behavior (2017) (1)
Female Reproductive Dysfunction (2020) (1)
Dysplasia Small Thymus at Birth: A Predictive Radiographic Sign of Bronchopulmonary (2013) (1)
Steroid hormones modulate placental GnRH and CRF production (1992) (1)
New trends in pharmacological treatments of endometriosis (2014) (1)
Diagnosis of Fetal Distress (2012) (1)
Ultrasound and Fetal Stress: Study of the Fetal Blink-Startle Reflex Evoked by Acoustic Stimuli (2008) (1)
Hormones and Inflammation: An Update on Endometriosis (2019) (1)
Possible involvement of inflammatory/reparative processes in the development of uterine fibroids (2015) (1)
Artificial neural network: control of ultrasound operator measurement errors (2007) (0)
Contents Vol. 79, 2015 (2015) (0)
Ultrasound Measurement of Fetal Membrane Thickness and Neonatal Outcome (2009) (0)
Effects of subchronic noise stress on plasma corticosterone levels, vaginal smear and both adrenal and ovarian ultrastructure in famale rats (1997) (0)
Physical Activity and Female Sexual Dysfunction: A Lot Helps, But Not Too Much. (2021) (0)
Parturition in two pregnant women with Addison's disease: changes of plasma corticotropin releasing factor levels. (1999) (0)
Effects of corticotropin-releasing hormone on cytokine release from human lymphomononuclear cells or lymphocytes in response to xenogeneic pancreatic islets (1998) (0)
PS-2-4 Colordoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With Sexual Dysfunction: A Gender Perspective (2020) (0)
Uterine Fibroids, Perceived Stress, and Menstrual Distress: a Key Role of Heavy Menstrual Bleeding (2022) (0)
How to improve the accuracy of diagnostic ultrasound to identify SGA fetuses (2011) (0)
Endocrine and paracrine control of progesterone secretion during pregnancy (2004) (0)
Intrahepatic Cholestasis of Pregnancy: Time to Redefine the Normal Reference Range of Total Serum Bile Acids (2021) (0)
Urinary tract endometriosis: how to predict and prevent recurrence after primary surgical excision. (2022) (0)
Increased endometrial Glycodelin A expression in patients with endometriosis (2011) (0)
Cytokines in placental physiology (1991) (0)
Cerebrospinal Fluid Activin a Measurement in Asphyx- Iated Full-term Newborns Predicts Hypoxic Ischemic (0)
Placenta accreta spectrum: experience of conservative surgery during cesarean section and clinical and radiological management during pregnancy and follow-up. (2022) (0)
Raf Kinase Inhibitor Protein (RKIP) expression and function in human myometrium and leiomyoma (2016) (0)
OC16.05: An ultrasound mapping system of pelvic deep infiltrating endometriosis to predict surgical difficulties (2014) (0)
Onward and upward (2013) (0)
Faculty Opinions recommendation of Risk of preterm birth, low birthweight and small-for-gestational-age infants in pregnancies with adenomyosis: A cohort study of the Japan Environment and Children's Study. (2019) (0)
Increased serum inhibin B levels in postmenopausal women with altered thyroid function. (2003) (0)
Management of infertility today (2013) (0)
Faculty Opinions recommendation of Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. (2019) (0)
Faculty Opinions recommendation of Anterior focal adenomyosis and bladder deep infiltrating endometriosis: is there a link? (2019) (0)
Human decidua and in vitro decidualized endometrial stromal cells produce corticotropin-releasing factor: changes of mRNA levels during pregnancy (1991) (0)
Abscessation of Bartholin's gland in children: two clinical case studies (2005) (0)
Endometriosis and the diagnosis of different forms of migraine: an association with dysmenorrhea (2023) (0)
Regulation of term and preterm labour, Castellina, Italy, 28 October-1 November 1997. (1998) (0)
Stress and ageing brain: Evaluation of the sympathetic and hypothalamic-pituitary-adrenocortical activities (1990) (0)
Stress and Pregnancy: CRF as Biochemical Marker (2008) (0)
13th World Congress of Gynecological Endocrinology (2007) (0)
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women (2005) (0)
Estimation of Fetal Biometric Parameters Referring to Regional Anthropometric Features. (2009) (0)
Faculty Opinions recommendation of Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. (2019) (0)
764: Is ultrasound fetal weight estimation useful to predict preterm birth? (2008) (0)
Foreword - SOGC Guidelines on Endometriosis: Diagnosis and Management (2010) (0)
ISF position paper on liver disease and pregnancy he Italian Association for the Study of the Liver ( AISF ) (2016) (0)
Trophoblast microRNAs (miRNAs), preeclampsia and intrauterine growth restriction. (2022) (0)
The relation between endometrioma and ovarian cancer. (2021) (0)
Faculty Opinions recommendation of Uterine adenomyosis and adenomyoma: the surgical approach. (2019) (0)
Physiological and clinical implications of placental hormones in human pregnancy (2004) (0)
P17.04: Placental location and delivery outcome in healthy pregnancy (2014) (0)
Evidence for urocortin gene expression in human endometrium (1999) (0)
Current topic Fetal sex and preterm birth q (0)
Abdominal circumference and estimation fetal weight to identify fetal growth restriction: A large cohort study. (2006) (0)
LH and Cortisol responses to Naloxone : relationship to normal and pathological puberal development. (1986) (0)
ESTROGENS MODULATION OF NEUROENDOCRINE FUNCTIONS IN POSTMENOPAUSE (1994) (0)
143 B-EP RESPONSE TO TRH/LHRH IN DIABETIC CHILDREN (IDDM) (1985) (0)
A new methodological approach for ultrasound estimation of fetal weight (2003) (0)
b-Endorphin and Reproduction: Evidence for Ovarian Participation (1989) (0)
Deep endometriosis is associated with the highest level of perceived stress: effect of surgical treatment (2016) (0)
HPV genotype distribution and age correlation in a selected Italian population undergoing conization. (2020) (0)
Faculty Opinions recommendation of The impact of adenomyosis on the outcome of IVF-embryo transfer. (2019) (0)
OP20.03: Bladder endometriosis: songraphic features useful for surgical treatment (2014) (0)
Placental hormones as putative markers of gestational diseases (2012) (0)
Contents Vol. 53, 2002 (2002) (0)
Endocrinology of Maternal-Placental Axis (2020) (0)
Pregnancy Outcomes Subsequent to Stillbirth—A Single Tertiary-Care Center Experience (2022) (0)
379 Maternal Plasma Urocortin I Levels in Preeclampsia and Fetal Growth Restriction Predict Neonatal Intraventricular Haemorrhage (2005) (0)
Hormonal strategy for the primary or secondary treatment of endometriosis (2012) (0)
Activin A in late-term pregnancy: the prediction of success to induction of labor (2016) (0)
| Preterm Birth | Taylor & Francis Group (2007) (0)
11 Met-enkephalin enhances steroidogenesis of cultured granulosa cells (1985) (0)
Urocortin-2 acts through the type 2 corticotrophin releasing hormone (CRH) receptor to regulate estradiol (E2) secretion by cultured human placental trophoblast cells. (2006) (0)
High maternal and fetal plasma urocortin levels at term labor (2003) (0)
Hypertension in Pregnancy and Related Health Outcomes in European Ethnic Minorities (2018) (0)
High Urinary Concentrations of Activin A in Asphyxi- ated Full-Term Newborns with Moderate or Severe Hypoxic Ischemic Encephalopathy Pasquale Florio, 1 Ste- (2007) (0)
Endometriosis: Treatment by local drug release systems (2006) (0)
Comparison between commercial product of oral misoprostol and vaginal dinoprostone for induction of labor (2023) (0)
SOGC Guidelines on Endometriosis: Diagnosis and Management (2010) (0)
Intraventricular hemorrhage and plasma activin a levels in preterm newborn (2003) (0)
Scrotoninergic and Dopaminergic Control of Beta-Endorphin Secretion in Obese Children and Adolescents (1988) (0)
Predictive Role of Novel Ultrasound Parameters for the Response to Induction of Labor in Postdate Pregnancy (2014) (0)
A New Surgical-Ultrasound Scoring System Helps in Mapping Pelvic Deep Infiltrating Endometriosis and Predicts Surgical Difficulties (2013) (0)
Spontaneus preterm birth and fetal weight (2011) (0)
Hemodynamic evaluation in patients with type 1 diabetes mellitus in pregnancy (2023) (0)
Involvement of opioids in reproductive function (1990) (0)
Faculty Opinions recommendation of Association between ultrasound features of adenomyosis and severity of menstrual pain. (2017) (0)
Markers of ovarian neoplasia: biochemical tools (2003) (0)
Fetal Abdominal Circumference and Fetal Weight Estimation: Gender-Related Difference of Growth Charts (2009) (0)
Sleep-disordered breathing and obstructive sleep apnea in pregnancy: the burden of patient BMI and risk of poor outcome (2023) (0)
Inhibin-related proteins in endometrium (2002) (0)
Corticotropin-releasing hormone facilitates early survival of discordant (bovine-to-rat) islet xenografts. (1998) (0)
Author's Reply (2000) (0)
Physical activity and female sexual dysfunction: too much of a good thing? (0)
Local production and action of prolactin-releasing peptide (PrRP) in human decidua. (2001) (0)
NORGBSTIMATE INCREASES PITUITARY AND HYPOTRALAYIC CONCERTRATIORS OF IMMDRORN4CTIVE BETA-ENDOPPHIBl (1989) (0)
Proteins and peptide factors in the trophoblast-endometrium interactions (1996) (0)
The human placenta as a neuroendocrine organ (1993) (0)
Increased expression of antim € hormone and its receptor in endometriosis (2014) (0)
Plasma opioid levels: a possible marker of neurotransmitter impairments in schizophrenia (1987) (0)
Opioid plasma levels: a marker of impaired central control in psychiatric disorders? (1987) (0)
Office hysteroscopy: an update. (2016) (0)
New Delivery for Classical Drugs: Intrauterine or Intravaginal (2010) (0)
Association between Pelvic Inflammatory Disease and Endometriosis. Outcomes on 311 Minimally-Invasive Procedures over 14 years’ Experience in a Third-level Referral Center (2019) (0)
Reduction of β‐Endorphin Levels in the Amniotic Fluid of Heroin Addicts (1986) (0)
P26.09: Image quality of the coronal plane of the uterus by 3D ultrasound comparison of four techniques based on the opinion of several experts (2017) (0)
Steroids and prematurity (2002) (0)
Placental hormone production: endocrine and paracrine regulation (1990) (0)
Faculty Opinions recommendation of Transvaginal Ultrasound for the Diagnosis of Adenomyosis: Systematic Review and Meta-Analysis. (2019) (0)
Growth hormone and cortisol plasma levels are influenced by beta-interferon or thymopentin administration in humans (1993) (0)
Activity of Hypothalamus-Pituitary-Adrenal Axis in Children with Hodgkin's Disease (1988) (0)
M065 VAGINAL DANAZOL IN WOMEN WITH ENDOMETRIOSIS: DIFFERENT SCHEDULE FOR A LONG‐TERM TREATMENT (2012) (0)
The use of a combined regimen of GNRH agonist plus a low‐dose oral contraceptive improves the spontaneous pulsatile lh secretory characteristics in patients with polycystic ovary disease (PLOD) after discontinuation of the treatment (2000) (0)
1 Hormones in the Physiology and Pharmacology of Pregnancy The Neuroendocrinology of Pregnancy (0)
P15.05: The use of 3‐4D ultrasound improves the diagnosis of spinal dysraphism (2004) (0)
Ultrasound Mapping System of Pelvic Deep Infiltrating Endometriosis: A Useful Instrument for Surgical Treatment and Counseling (2014) (0)
Different ultrasound approaches to define fetal growth restriction: a large cohort study (2001) (0)
Subject Index Vol. 57, 1993 (1993) (0)
TGF beta family members function in uterine healthy and fibrotic smooth muscle cells (2013) (0)
Hormonal Replacement Therapy, Cognitive Disturbances, and Alzheimer’s Disease (1997) (0)
Endometriosis and Cancer: Prevention and Diagnosis (2020) (0)
Role of placental inhibin and activin (2001) (0)
Ogilvie's Syndrome in an obstetric patients. (2015) (0)
The obstetric syndromes: clinical relevance of placental hormones (2013) (0)
Puberty and body weight : the pole of circulating opiotds (1984) (0)
Changes of allopregnanolone levels after LHRH and ACTH administration in girls with pubertal disturbances (2001) (0)
Maternal serum inhibin A and activin A concentration in miscarriage (2004) (0)
Placental activin and inhibin: new hormones in human pregnancy. (1993) (0)
Office hysteroscopy in pre- and post-menopausal women: a predictive model (2020) (0)
Impact of Dienogest on Endometriomas Transvaginal Ultrasound Features and Symptoms. (2015) (0)
Artificial neural networks can improve the accuracy of ultrasonographic fetal biometry (2006) (0)
Changes of serumn allopregnanolone levelsa during GnRH analogue therapy in girls with central precocious puberty. (2002) (0)
Diabetes is associated with ultrastructural defects in sperm (2002) (0)
High Urinary Concentrations of Activin A in Asphy- xiated Full-Term Newborns with Moderate or Severe (2007) (0)
Three-dimensional transvaginal ultrasound in the diagnopsis of adenomyosis (2004) (0)
Altered Balance in Pro-Inflammatory and Anti-Inflammatory Cytokines in Preterm Cervical Ripening (2009) (0)
A Questionnaire Integrated with the Digital Medical Record Improved the Coverage of a Control Program for Congenital Chagas Disease in Tuscany, Italy (2023) (0)
Bleeding and bowel obstruction in giant ovarian serous carcinoma – a video vignette (2020) (0)
[Neonatal adaptive phenomenon: secretion of beta-lipotropin, and beta-endorphin in the first week of life]. (1981) (0)
Faculty Opinions recommendation of Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. (2019) (0)
Urocortin in endometrial and ovarian cancer: low lewels are related to an immune system regulations (2003) (0)
Temporary Reduction of Plasma B-Endorphin in Patients Suffering of Premenstrual Syndrome (1985) (0)
Plasma opioids in the 1st week of life (1981) (0)
Faculty Opinions recommendation of Guiding histological assessment of uterine lesions using 3D in vitro ultrasonography and stereotaxis. (2019) (0)
High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup. (2020) (0)
Three dimensional ultrasound and ovarian masses (2004) (0)
AB0334 THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) (2021) (0)
The New Journal (2009) (0)
Scientific Program Schedule (2009) (0)
Faculty Opinions recommendation of Development of a clinical prediction model for diagnosing adenomyosis. (2019) (0)
Umbilical cord blood inhibin A and activin A levels in healthy and pathological conditions (2001) (0)
Changes of Activin A Secretion in Gestational Diseases (1997) (0)
Maternal plasma calcitonin gene-related peptide levels do not change during labor and are not influenced by delivery route. (2001) (0)
THE IMPAIRMENT OF THE HYPOTHALAMIC-PITUITARY AXES IN PATIENTS WITH THALASSEMIA MAJOR IS NOT DEPENDENT FROM THE THERAPEUTICAL MANAGEMENT (1990) (0)
Placental hormone release: Putative role of regulatory factors (1991) (0)
Faculty Opinions recommendation of MRI for adenomyosis: a pictorial review. (2019) (0)
Circadian changes of hypothalamic beta-endorphin are influenced by estrogens (1990) (0)
Maternal, placental and fetal urocortin levels at term and preterm (2005) (0)
Epigenetics, endometriosis and sex steroid receptors: An update on the epigenetic regulatory mechanisms of estrogen and progesterone receptors in patients with endometriosis. (2023) (0)
Faculty Opinions recommendation of Minimally invasive treatment of adenomyosis. (2019) (0)
Endometriosis-Induced Pain: The Treatment Strategy (2020) (0)
Is it time to change the diagnostic thresholds for Intrahepatic Cholestasis of pregnancy? (2023) (0)
Alternative terapaeutiche neuroendocrine (1992) (0)
Opiatergic mechanisms in analgesia induced by transcutaneous electrical nerve stimulation (1984) (0)
PCOS and pregnancy: Impact of endocrine and metabolic factors (2015) (0)
Interactions between gonadal steroids and opiods (1990) (0)
Mechanisms and Pathogenesis of Adenomyosis (2022) (0)
Effects of central opioid peptides on gonadotropin secretion at puberty (1992) (0)
O-136 Once-daily relugolix combination therapy results in sustained reduction in symptoms and improved quality of life in women with uterine fibroids treated over 52 weeks (2021) (0)
Chronobiological derangement of pituitary hormones in hypothalamic amenorrhea (1996) (0)
Immunohistochemical localization of inhibin subunits in bovine oviduct during oestrus cycle (1992) (0)
12 B-EP changes in pharmacologically induced-menstrual cycles (1985) (0)
Aging Brain and Hypothalamic-Pituitary-Adrenal Function: Implications for Dementia of the Alzheimer Type (1992) (0)
533 Predictive role of radiomic for post-operative complications of lymphadenectomy in ec patients (2020) (0)
Predictive value of hormone measurements in gestational diseases (2001) (0)
Serum HGH, PRL and energetic fuel (glucose and FFA) levels during an endurance athletic race. (1988) (0)
NALTREXONE TREATMENT RESTORES MENSTRUAL CYCLES IN PATIENTS WITH WEIGHT LOSS-RELATED AMENORRHEA (1996) (0)
Eclampsia: how to optimize maternal outcomes? Experience of a referral centre (2023) (0)
Review Paracrine/autocrine control of female reproduction (2000) (0)
LH pulsatile secretion in normo or hypogonadotropic secondary amenhorrea: evidence of a constant pulsatile release from the gonadotropes (1991) (0)
OP08.01: Fetal weight estimation at term is not influenced by maternal BMI and weight gain (2014) (0)
Faculty Opinions recommendation of Pathogenesis of uterine adenomyosis: invagination or metaplasia? (2019) (0)
EP27.07: Normal/arcuate vs septate uterus diagnostic test accuracy and best cut‐off values for currently used measurements (2017) (0)
A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy [La miomectomia per via laparoscopica: Confronto tra elettrochirurgia e bisturi ad ultrasuoni] (2009) (0)
OC13.05: Ultrasound evaluation of localization of pelvic deep infiltrating endometriosis (DIE) and correlation to surgical classifications (2012) (0)
Endometrial Activin A Concentrations Correlate with Successful Pregnancy at Subsequent Intrauterine Insemination (2009) (0)
COVID-19 in pregnancy may significantly affect fetal growth (2023) (0)
Fetuses with Normal Birth Weight but Evidence of Declined Fetal Growth Curve at Term and Risk of Adverse Perinatal Outcome (2014) (0)
Obstetric outcome in pregnant women with heart disease, a tertiary care center hospital experience in light of ESC guidelines (2023) (0)
OPIOID-PEPTIDES IN EMBRYO AND FETUS (1986) (0)
Aging modifies the hormonal responses in women. (1989) (0)
Doctor-Midwife vs. Patient Relations Questionnaire (2015) (0)
Ultrastructural sperm analysis in men with insulin-dependent diabetes (2002) (0)
EP27.11: Normal/arcuate vs septate uterus interobserver reliability/agreement of currently used measurements (2017) (0)
Faculty Opinions recommendation of Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. (2019) (0)
Subject Index Vol. 53, 2002 (2002) (0)
RKIP and Cytotrophoblast (2012) (0)
Endometrial Transporters and Cytochrome P450 Family Member in Endometriosis (2012) (0)
Faculty Opinions recommendation of Endometrial stem/progenitor cells: the first 10 years. (2019) (0)
169: A new artificial neural network for monitoring ultrasound operator measurement errors (2007) (0)
Faculty Opinions recommendation of A sonographic classification of adenomyosis: interobserver reproducibility in the evaluation of type and degree of the myometrial involvement. (2019) (0)
ACTH, beta-endorphin, beta-lipotropin and cortisol response to an agonistic athletic performance is related to the energetic characteristics and to the duration of the competition. (1987) (0)
Letter to the EditorActivin A: A Possible Marker for Liver Transplant Outcome (2004) (0)
P26.10: Normal/arcuate vs septate uterus agreement among experts' subjective impression evaluating the coronal plane of the uterus on 3D ultrasound (2017) (0)
Heat-killed Lactobaciullus rhamnosus GG increases Urocortin 1 release in human term primary trophoblast cells (2009) (0)
[Non-specific pituitary responses in insulin-dependent diabetes mellitus in children and adolescents]. (1995) (0)
[The significance of screening tests for aneuploidies in populations at low and high maternal-age-related risk]. (2005) (0)
The challenge of endometriosis for female sexual health. (2023) (0)
Opposite effects on β-endorphin and ACTH plasma levels following treatment with animal hypnosis (1984) (0)
Fetal nondiabetic-macrosomia: risk factors for pregnancy adverse outcome and comparison of two growth curves in the prediction of cesarean section (2021) (0)
13th World Congress of Gynecological Endocrinology (2001) (0)
754: Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia (2008) (0)
NEUROENDOCRINE RESPONSES RELATED TO STRESS IN CHILDREN WITH PSYCHOPATHOLOGY (1992) (0)
2010 Roadmap for the Journal of Endometriosis (2010) (0)
Maternal S100B levels predict perinatal brain damage in intrauterine growth retardation. (2005) (0)
Faculty Opinions recommendation of Molecular characteristics of the endometrium in uterine adenomyosis and its biochemical microenvironment. (2019) (0)
Can we consider resistance index (RI) value as a new parameter to decide the treatment of connective tissue diseases during pregnancy (2007) (0)
Expression of CRH/urocortin gene family in mouse gestational tissues during late pregnancy (2012) (0)
Clarification of scope for Human Reproduction and Molecular Human Reproduction. (2015) (0)
Danazol-loaded IUD treatment decreases uterine volume and serum CA125 in women with adenomyosis (2002) (0)
Reduced Fuel Consumption Engine for a CO (2003) (0)
Office hysteroscopy: an update. (2016) (0)
Faculty Opinions recommendation of Ultrasound diagnosis of endometriosis and adenomyosis: State of the art. (2019) (0)
Previous surgery for endometriosis: a further risk for obstetric complications? (2023) (0)
Faculty Opinions recommendation of Sonographic signs of adenomyosis are prevalent in women undergoing surgery for endometriosis and may suggest a higher risk of infertility. (2019) (0)
OC29.03: T‐shaped uterus by Congenital Uterine Malformation by Experts (CUME): suggested definition based on three criteria (2019) (0)
Advances in targeting estrogen synthesis and receptors in patients with endometriosis (2022) (0)
L4. Placental inflammatory factors and preeclampsia. (2011) (0)
Does chronic low molecular weight heparins use during pregnancy increase the risk of postpartum hemorrhage? (2022) (0)
Follow up of PAS (placenta accreta spectrum) disorders treated with conservative management (2023) (0)
Feto-maternal biology and ethics of human society (2005) (0)
Urocortin 2 and Urocortin 3 mRNA Expression and Peptide Localization Changes in Trophoblast Specimens throughout Pregnancy and Birth. (2009) (0)
The ultrasound evolution of fetal abdominal circumference as tool for detecting macrosomia (2008) (0)
Ultrasound and diagnosis of abnormal uterine bleeding (2004) (0)
Endocrinology of Delivery (2019) (0)
Allopregnanolonelevelsdecreaseaftergonadotropin-releasing hormoneanalogstimulationtestingirlswithcentral precociouspuberty (2011) (0)
New challenge in fetal growth evaluation (2010) (0)
THE MATERNAL-FETAL MEDICINE: AN UPDATE (2013) (0)
Ultrasonographic prediction of fetal macrosomia revisited. (2005) (0)
Chronic lisuride treatment decrease ACTH but not 3-EP and β-LPH plasma levels in children (1984) (0)
Updating the role of radiotherapy in the management of epithelial ovarian cancer (2001) (0)
OC16.03: Pre- and post-operative clinical and transvaginal ultrasound findings of adenomyosis in patients with deep infiltrating endometriosis (2014) (0)
The electronic engineering master index : a subject index to electronic engineering periodicals January, 1925 to June, 1945 (1945) (0)
Faculty Opinions recommendation of Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. (2019) (0)
EP27.04: Normal/arcuate vs septate uterus agreement between currently recommended cut‐off values for measurements and experts' opinion (2017) (0)
Latency from premature preterm rupture of membranes to delivery and correlation with gestational age (2023) (0)
Progesterone receptor ligands for the treatment of endometriosis. (2022) (0)
Serum Activin A Testing Increases the Sensitivity and Specificity of Ultrasounds and Hysteroscopy in Endometrial Cancer (2010) (0)
8th World Congress of Gynecological Endocrinology : Florence, Italy, December 6-9, 2000 (2001) (0)
10 Steroid hormones modulate the hypothalamic opioid in ovariectomized rats (1985) (0)
Faculty Opinions recommendation of Estrogen-progestins and progestins for the management of endometriosis. (2017) (0)
Diagnostic role of inhibins and activins in adverse pregnancy outcomes (2008) (0)
Regional anthropometric features to identify newborns at higher risk of poor outcome (2012) (0)
WELCOME LETTER: 1st European Congress on Endometriosis - November 29 - December 1, 2012, Siena - Italy (2012) (0)
Preeclampsia, growth retardation: estimation of fetal weight (2010) (0)
Uncomplicated urinary tract infections in pregnancy (2020) (0)
OC13.07: Ultrasound evaluation of pelvic deep infiltrating endometriosis (DIE): accuracy in differentiating rectal from sigmoid lesions (2012) (0)
The impact of endometriosis in women’s health: the current and the future fields of investigation (2012) (0)
High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target. (2023) (0)
Paracrynology of the placenta (2005) (0)
The role of transvaginal ultrasound in emergency contraception (2001) (0)
Role of Endogenous Corticotropin-Releasing Factor in Modulating the Pituitary Response to Stress (1989) (0)
The ESGE Junior Platform (2009) (0)
What is the role of glycemic control in the development of preeclampsia among women with type 1 diabetes? (2021) (0)
The evaluation of fetal middle cerebral artery Doppler correlates with the onset of labor (2008) (0)
Role of transvaginal ultrasonography in postcoital contraception (2004) (0)
Elevated nuchal translucency, is it time to discuss the cut off? (2023) (0)
Universal cervical length screening after 24 weeks is not useful (Winner of the SIMP Award, in memory of Professor J. Francesco Branconi) (2023) (0)
Faculty Opinions recommendation of Long-term use of dienogest in the treatment of painful symptoms in adenomyosis. (2019) (0)
pRb2/p130 AND VEGF EXPRESSIONS IN ENDOMETRIAL CARCINOMA IN RELATION TO ANGIOGENESIS AND TUMOR HISTOPATHOLOGIC GRADE: 00033 (2007) (0)
Hypothalamic amenorrhea and cardiovascular hormones: Changes of plasma calcitonin gene-related peptide and atrial natriuretic peptide levels (1998) (0)
M070 ENDOMETRIAL FOXL2 EXPRESSION CHANGES THROUGHOUT MENSTRUAL CYCLE (2012) (0)
Bladder Endometriosis: The Usefulness of 2D and 3D Transvaginal Sonography for Surgical Treatment (2014) (0)
4. Preeclampsia and Placental Regulatory Factors(III. Recent Advances in Maternal-Fetal Medicine,International Symposium) (2007) (0)
Faculty Opinions recommendation of Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study. (2019) (0)
A34 Neuroendocrine changes and climaterium (1996) (0)
Faculty Opinions recommendation of Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. (2019) (0)
Extending cervicoplastic surgery: an alternative technique to overcome the limitation of office hysteroscopy (2020) (0)
Clinical Safety of New Tri-Phasic Oral Contraceptive Pill (1991) (0)
Plasma beta‐endorphin, cortisol and norepinephrine responses to physical and metabolic stressors in young and elderly humans (1992) (0)
CURRENT STATUS OF INTERVENTIONS (2007) (0)
Recent research in gynecological endocrinology : proceedings of the free communications and poster sessions of the 8th World Congress of Gynecological Endocrinology, Florence, Italy, December 2000 (2001) (0)
Neuroendocrinology of the climacteric period and hormonal replacement therapy (2020) (0)
Third level care experience during SARS-CoV-2 pandemic (2023) (0)
Adenomyosis: is an endocrine-related uterine dysfunction? (2022) (0)
Enhanced recovery after gynecological surgery: comparison between intrathecal and intravenous morphine multimodal analgesia. (2021) (0)
Different levels of Allopregnanolone in girls with precocious pubarche and central precociuos puberty (2003) (0)
28 Blink-Startle Reflex Habituation in 30–34 Week Low-Risk Fetuses (2005) (0)
A Calculation Methodology for Cam Overlap Optimization Towards Combustion Quality at Idle in IC SI Engines (2003) (0)
Contents Vol. 84, 2003 (2003) (0)
Gonadotropins and Gonadal Steroids (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Felice Petraglia?

Felice Petraglia is affiliated with the following schools:

Felice Petraglia's Academic­Influence.com Rankings

Why Is Felice Petraglia Influential?

Felice Petraglia's Published Works

Published Works

What Schools Are Affiliated With Felice Petraglia?

Felice Petraglia's AcademicInfluence.com Rankings